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Programming Synthetic Feedback
Using Designer Proteins
Andrew H Ng
Abstract
Feedback plays a key role in nearly all biological processes, from the cell cycle to
chemotaxis. Despite the clear importance of feedback to cells, synthetic biologists have yet
to invent a truly modular device for performing feedback on proteins. Existing methods for
performing feedback have been designed for control of specific pathways or molecules, with
limited tunability. To this end, we leveraged recent advancements in protein design to
design a completely de novo, static, five-helix “Cage” with a single interface that can
interact either intra-molecularly with a terminal “Latch” helix or inter-molecularly with a
peptide “Key”. Encoded on the Latch are functional motifs for binding, degradation, or
nuclear export that function only when the Key displaces the Latch from the Cage. Using
one of these designer switches, degronLOCKR, we were able to regulate degradation of a
variety of cargoes, including transcription factors, dCas9, and kinases. The modularity
afforded by the de novo designed LOCKR switches offers distinct advantages over previous
vii
efforts to engineer cellular circuits, which have been limited to repurposing modular protein
domains from nature. Leveraging the plug-and play nature of degronLOCKR, we
implemented feedback control on both endogenous signaling pathways and synthetic gene
circuits. We first generated synthetic negative feedback in the yeast mating pathway via
fusion of degronLOCKR to endogenous signaling molecules, illustrating the simplicity with
which this strategy can be used to rewire complex endogenous pathways. We next
benchmarked degronLOCKR-mediated feedback control on a synthetic gene circuit to
quantify its feedback capabilities and operational range. The designer nature of
degronLOCKR enables simple and rational modifications to tune feedback behavior in
both the synthetic circuit and the mating pathway. De novo protein design promises to
greatly expand the realm of possibility of synthetic biology with a toolkit of composable,
modular, and tunable parts that are also bio-orthogonal.
viii
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Chapter 1
Introduction
The field of synthetic biology is beginning to realize its potential, with applications of
engineered cells ranging from microbial factories to produce valuable chemicals1, to
environmental sensors2, to immune cells that can detect and treat cancer3. Despite major
advances, a large gap still exists between capabilities for engineering biological systems
versus electronic devices. One major reason for this gap is the effect of context in biological
systems4, making the development of engineered cells closer to an art than a science.
Despite this difference, synthetic biologists often look to electronic systems for inspiration
in the construction of synthetic devices such as logic gates5 and oscillators6 inside cells.
One key behavior that engineered cells generally lack is feedback control. Feedback is a
cornerstone of modern technology and plays an essential role in modern devices ranging
from the humble thermostat to the complex commercial airliner.
In its simplest form, feedback control occurs when measurement of an output is used to
generate an error signal, which is used to influence the process to drive the error signal as
close to zero as possible. Feedback enables robustness in systems by rejecting the effect of
disturbances and stabilizing a desired output. Existing solutions for implementing feedback
1
in biological systems are either limited to transcriptional control (ie. producing a
transcription factor that acts as a repressor for a promoter)7, or control of specific
pathways (MAPK pathways)8. Although these methods have were successful in the
context for which they were developed, it would be advantageous to have a method for
implementing feedback that does not require re-engineering for each application.
An appealing solution for modular control of signaling networks is protein degradation.
Protein stability is intricately regulated inside cells, and all proteins are eventually recycled
by the proteasome. Small signal sequences that regulate degradation have been isolated
and are known as degrons. These sequences can either be constitutively active or regulated
by signals inside the cell such as phosphorylation9. Drug inducible degrons10,11 have also
shown great utility for conditional studies of protein stability. Degrons are thus a modular
solution for the regulation of proteins, but a degron that can be conditionally activated by
a genetically encoded mechanism does not yet exist. Because most networks inside of a cell
terminate in a transcriptional event, it would be advantageous to have a trigger for
degradation that could be produced by the output of a network of interest.
To overcome this challenge, we turned to the field of protein design. Protein design has
experienced a renaissance with major advancements to Rosetta enabling the design of
sequences that will fold into a desired structure12. De novo designed proteins promise to
revolutionize the biological sciences, with applications ranging from flu vaccines13 to
immunotherapies14. Despite these successes, engineering allostery has still remained a
challenge. In this work, I will describe the design of the first de novo molecular switch that
can perform a biological function in vivo. The modularity and bio-orthogonality of this
switch enabled the first truly modular implementation of feedback control on biological
circuits.
Our switch technology, termed Latching Orthogonal Cage Key pRoteins (LOCKR), is
capable of inducible activation of a signal peptide of interest. LOCKR consists of two
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parts: the Switch, which cages the signal peptide, and the Key, which activates the Switch
and reveals the signal peptide. We were able to achieve successful caging of several signal
peptides, including bim, a nuclear export signal (nes), and a degron. By embedding a
degron in the Switch, we created degronLOCKR, the first small peptide inducible degron.
Fusion of the degronSwitch to a protein of interest enabled inducible degradation in the
presence of the Key. We showed that degronLOCKR could be used to control the stability
of a variety of proteins, including fluorescent proteins, transcription factors, dCas9, and
kinases. Using this tool, we were able to implement feedback control on both endogenous
and synthetic pathways in a plug-and-play manner. Additionally, the tunability and
designer nature of degronLOCKR enables simple and rational tuning of the feedback
controller for programmable behavior.
Modularity is an oft-stated goal for synthetic biologists, but can often be difficult to
achieve because of cross-talk between parts that have been repurposed from other
organisms or pathways. This limitation is universal to the field of engineering biology,
which relies on either naturally occurring proteins or evolved versions of the same to
perform functions inside cells. Our work demonstrates that de novo protein design can
overcome these challenges with clever design of new devices for synthetic biology. This is
the first example of designer proteins being leveraged for use in genetic circuits, but
certainly will not be the last. As protein design continues to mature, it may become a
cornerstone for synthetic biologists seeking to reprogram cells.
3
Chapter 2
De novo design of bioactive protein
switches
2.1 Abstract
Allosteric regulation of protein function is widespread in biology, but challenging for de
novo protein design as it requires explicit design of multiple states with comparable free
energies. We explore the possibility of de novo designing switchable protein systems
through modulation of competing inter and intra-molecular interactions. We design a
static, five-helix Cage with a single interface that can interact either intra-molecularly with
a terminal Latch helix or inter-molecularly with a peptide Key. Encoded on the Latch are
functional motifs for binding, degradation, or nuclear export that function only when the
Key displaces the Latch from the Cage. We describe orthogonal Cage-Key systems that
function in vitro, in yeast and in mammalian cells with up to 40-fold activation of function
by Key. The design of switchable protein function controlled by induced conformational
change is a milestone for de novo protein design and opens up new avenues for synthetic
4
biology and cell engineering.
2.2 Introduction
There has been considerable progress in the de novo design of stable protein structures
based on the principle that proteins fold to their lowest free energy state. These efforts
have focused on maximizing the free energy gap between the desired structure and all other
structures, and have resulted in a wide range of stable proteins that exclusively populate
the designed state12,15–17. Designing proteins that can switch conformations is more
challenging, as multiple states must have sufficiently low free energies relative to the
unfolded state, and free energy differences between the states must be small enough that
switching can be toggled by an external input18,19. Recent advances in designing systems
with multiple states include a transmembrane ion transporter20 and Gβ1 variants that
dynamically exchange between two related conformations21; however, a method for the de
novo design of modular, tunable protein systems that switch conformational states in the
presence of an external input has not yet been achieved.
We set out to design de novo Switchble protein systems guided by the following
considerations. First, programming free energy differences between two states is more
straightforward in a system governed by inter- and intra-molecular competition at the same
site than by allosteric activation at distant sites22–24 because many of the residue-level
interactions can be similar if not identical. Second, a stable protein framework with an
extended binding surface available for the competing interactions is more programmable
and less likely to engage in off-target interactions than a framework that only becomes
ordered upon binding25,26. These features are described by the abstract system in Fig 2.1a,
which undergoes thermodynamically-driven switching between binding-competent and
binding-incompetent states. A Latch (blue) contains a peptide sequence (orange) that can
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bind a Target (yellow) unless blocked by intramolecular interactions to a Cage (cyan); a
Key (green) that binds more tightly to the Cage outcompetes the Latch, allowing the
peptide to bind the Target. The behavior of such a system is governed by binding
equilibrium constants for the individual subreactions (Fig. 2.1a): Kopen, the dissociation of
Latch from Cage; KLT , the binding of Latch to Target; and KCK , the binding of Cage to
Key. When the Latch-Cage interaction is too weak (Fig. 2.1b, red and orange curves, see
Supplementary Information), the system binds Target in the presence of little to no Key
and the fold induction by Key is low, while when the Latch-Cage interaction is too strong
(purple curve), the system only partially binds Target even at high Key concentrations.
The Latch-Cage interaction affinity that gives optimal switching (Fig. 2.1b, blue curve left,
green curve right) is a function of the Latch-Target binding affinity.
2.3 LOCKR Design
To implement the Switchble system of Fig. 2.1a, we chose structural features amenable to
tuning the affinities of the Cage-Latch and Cage-Key interactions over a wide dynamic
range. Helical interfaces are dominated by sidechain-sidechain interactions, which can be
more readily tuned than the backbone hydrogen-bonding interactions between β-strands27.
To allow fine control over the specificity and relative affinities of the Cage-Latch and
Cage-Key interactions, we chose to design interfaces containing buried hydrogen bond
networks; as in DNA base-pairing, specificity can be altered by minor changes to hydrogen
bond donors and acceptors28. As a starting point, a designed homo-trimer of α-helical
hairpins mediated by hydrogen bond networks (5L6HC31) was connected into two
monomeric frameworks by designing short unstructured loops between the subunits (Fig.
2.1c). In the five-helix framework, there is an open binding site for a sixth helix added in
trans; this site is filled by a sixth helix in cis in the six-helix framework.
6
The five-helix (Cage) and six-helix (Cage plus Latch) designs expressed in E. coli were
largely monomeric by size-exclusion chromatography (Fig 2.6), and remain folded up to 5
M guanidine hydrochloride (Fig. 2.1d). Small-angle x-ray scattering (SAXS) spectra of the
connected designs are similar to that of the starting trimer and indicative of well-folded
proteins29 (Fig. 2.1e, Table 2.1; the greater deviations for the five-helix design likely
reflects the loss of a helix). The five-helix framework, but not the six-helix framework,
bound GFP fused sixth-helix in a pull-down assay (Fig. 2.1f); the latter result is expected
since if the interfaces are otherwise identical and the connecting linker unstrained, the
intramolecular interaction should outcompete its intermolecular counterpart because of the
reduced entropic cost of formation of intramolecular interactions. To enable the Key to
outcompete the Latch, we tuned Kopen by incorporating mutations in the Latch that
weaken its interaction with the Cage30–32. A Cage-Latch framework with two serine
substitutions in the Latch (V223S/I238S) bound Key nearly as strongly as the five-helix
Cage without the Latch (Fig. 2.1f, Fig. 2.7); the two serines likely weaken the Cage-Latch
interaction by decreasing the helical propensity of the Latch and increasing the cost of
desolvating the Latch when it binds the Cage. In the absence of Key, the Latch is bound to
the Cage as in the original monomer (their SAXS spectra are nearly identical and closely
match those of the design models; Fig. 2.1e, Fig. 2.6), but the guanidine hydrochloride
denaturation midpoint and ∆Gfolding are more similar to the truncated five-helix design
indicating the mutations are destabilizing (Fig. 2.1d,e; Fig. 2.6). We call such Cage-Latch
frameworks Switches, and the Switch-Key pair LOCKR for Latching Orthogonal Cage-Key
pRoteins for the remainder of this article.
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2.4 LOCKR Inducible Bim-Bcl2 Binding
We reasoned that a functional peptide sequence embedded in the Latch could be rendered
inactive until Key binding frees the Latch from the Cage, and that activation could be
tuned by modulating the thermodynamic parameters outlined in Fig. 2.1a. To install
function into LOCKR, we selected the Bim-Bcl2 interaction central to apoptosis as a model
system, and sought to cage Bim such that binding to Bcl2 only occurred in the presence of
Key. Three Bcl2 binding peptides33,34 (Fig 2.8a) were chosen to sample a range of KLT and
the base LOCKR structure was manipulated to sample a range of KCK and Kopen. The
three sequences were embedded in the Latch by sampling different helical registers such
that residues involved in binding to Bcl2 are sequestered in the Cage-Latch interface (Fig
2.8b,c), optimizing for the burial of hydrophobic residues and surface exposure of polar
residues. (Supplementary Information). To enable sampling of a broader range of Kopen
and KCK values, we expanded the available interaction surface area for the Cage:Latch and
Cage:Key interactions by lengthening the helices in the Switch by 5-, 9-, or 18-residues (Fig
2.8d), taking advantage of the modular nature of parametric de novo helical bundles15,35,36.
Increasing Cage:Latch affinity (decreasing Kopen) makes the system more off in absence of
Key, and extending the Key to increase affinity for the Cage could allow it to better
outcompete the Latch once Kopen is appropriately tuned (increase Kopen relative to KCK).
A design caging full length Bim with Cage, Latch and Key each extended by 18-residues is
fully off in the absence of Key (Fig. 2.2a left). Strongest inducible binding was observed
with a Latch truncated by 9 residues and a full-length Key (Fig. 2.2a right); the Key
buries more surface area and hence outcompetes the Latch for Cage binding. Addition of
Key activated Target binding by BimSwitch over forty-fold (Fig. 2.2b), comparable to or
better than naturally occurring protein interaction switches37–39.
According to the model in Fig. 2.1a, the range of Key concentrations over which
BimSwitch activates is controllable by tuning KCK and KLT . We investigated using BLI
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(Biolayer Interferometry) to monitor binding to Bcl2 in response to different length Keys,
hence different KCK (Fig. 2.2c). These activate BimSwitch at different concentrations: a
40-residue Key produces no activation (pale green), a 45-residue Key activates with an
EC50 of 230 ± 58 nM (green), and the full-length 58 residue Key activates with an EC50 of
27.0 ± 2.8 nM (dark green, Fig. 2.2b,c). To probe how LOCKR activation depends on
KLT , we used different affinity targets: Bcl2, BclB, and Bak bind non-caged Bim with Kds
of 0.17 nM21, 20 nM21, and 4.2 µM (Fig. 2.9a), respectively. Consistent with the Fig. 2.1a
model, activation of BclB binding requires higher Key concentrations than activation of
Bcl2 binding, while Bak does not bind in this range of Key concentrations (Fig 2.9b). The
equilibria involved in activation are indeed sensitive to small changes in the binding free
energy of both Key and Target.
To enable independent caging and specific unlocking of different protein functions in the
same cell, we sought to create orthogonal Switch-Key pairs by incorporating different
hydrogen bond networks at the Cage-Latch/Key interface through Rosetta design40,41 (see
Supplementary Information). Designs BimLOCKRb and BimLOCKRc show 22-fold and
8-fold activation with their cognate Keys (Fig. 2d). The original BimLOCKR
(BimLOCKRa) and the new designs are mutually orthogonal; each Switch is activated only
by its cognate Key at concentrations up to 5 µM (Fig. 2.2e), illustrating the power of the
buried hydrogen bond network approach to achieving specificity.
2.5 LOCKR inducible protein degradation
We sought to couple Switch activation to protein degradation in living cells by caging the
cODC degron42. The caging strategy employed for Bim was used to embed three variants
of cODC into Switcha: the wild-type sequence, wild-type with a proline removed (since
proline destabilizes α-helices), and the central dipeptide CA (Fig 2.10). Designs were
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characterized in S. cerevisiae using a dual-inducible expression system43 to independently
titrate Switch fused to yellow fluorescent protein (YFP) expression and Key fused to blue
fluorescent protein (BFP) expression (Fig. 2.3a). Key induced degradation was dependent
on the presence of the degron in the Switch, and was not observed when YFP was fused to
either BimSwitcha or Switcha (Fig 2.5). We optimized the amount of inducible degradation
by varying the Switch toehold length to tune Kopen (Fig 2.10), and found the Switch with
proline removed and a 12-residue toehold had the largest dynamic range (hereafter referred
to as degronSwitcha). Keys of different lengths (43 residues versus 55 residues) produced a
similar dynamic range of Switch activation, but a higher Key concentration was required
for maximal activation for the shorter Key (Fig. 2.3b; Fig 2.11), as in the case of
BimLOCKR in vitro (Fig. 2.2d), suggesting the Fig 2.1a model holds in living cells. Key
fluorescence was independent of degronSwitcha concentration (Fig 2.11), suggesting the
Key is not co-degraded with degronSwitcha. We next examined the dynamics of activation,
and found that the amount of YFP-degronSwitcha starts decreasing shortly after induction
of Key, reaching a new steady-state in 3 hours (Fig 2.3c). Taking into account the rates of
synthesis (Supplementary Information), we estimate a 24 minute half-life for activated
degronSwitcha, which is similar to the previously measured 11-30 minutes
42 for the cODC
degron.
We next designed orthogonal degronLOCKRs to enable Key-induced degradation of
different proteins in the same cell by installing the proline-removed cODC degron in
LOCKRb and LOCKRc. YFP fusions of these designs were expressed together with each
Key variant fused to cyan fluorescent protein (CFP). degronLOCKRa and degronLOCKRc
were strongly activated by their cognate Keys, but not by each other’s Key (LOCKRb did
not activate; Extended Data ??). To test the orthogonality of degronLOCKRs in the same
cell, we constitutively coexpressed degronLOCKRa and degronLOCKRc fused to YFP and
red fluorescent protein (RFP), respectively, and titrated expression of each Key. Expression
of Keya led to selective degradation of YFP but not RFP, and expression of Keyc, to
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selective degradation of RFP but not YFP (Fig. 2.3d).
To evaluate degronLOCKR function in mammalian cells, we expressed degronSwitcha fused
to mCherry RFP in human HEK293T cells, and measured RFP fluorescence in the
presence and absence of Key. A redesigned asymmetric degronSwitcha with an 8-residue
toehold (see Supplementary Information; 2.13) triggered a 11-fold reduction in mean RFP
fluorescence in the presence of Key (Fig. 2.3e).
2.6 degronLOCKR control of gene expression in live
cells
We sought to use degronLOCKR to modulate the intracellular concentration of a synthetic
transcription factor and dCas9 in yeast. We independently expressed a zinc-finger based
synthetic transcription factor (synTF)44 fused to RFP-degronSwitcha, and Keya-BFP-NLS.
Activity of the synTF was measured using YFP produced by the synTF promoter (Fig.
2.4a, left). Key induction triggered a 61% decrease in RFP (the transcription factor), and
an 82% decrease in YFP (the transcription factor target), respectively (Fig. 2.4a, right; Fig
2.14a). To investigate the generality of transcriptional control by degronLOCKR, an
activating dCas9-VP64 fusion45 was fused to RFP-degronSwitcha and targeted to a tet
operator site with a constitutively expressed sgRNA to induce expression of YFP (Fig.
2.4b, left). A 78% reduction of RFP and 41% reduction of YFP was observed upon
induction of Key (Fig. 2.4b, right; Fig 2.14b). Together, these results demonstrate the
modularity and functionality of degronLOCKR for controlling the stability of proteins in
live cells.
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2.7 LOCKR inducible nuclear export
To investigate inducible control over nuclear localization, we caged a nuclear export
sequence (NES46) in Switcha (Fig 2.15 a,b) using the same strategy as for Bim and cODC,
and fused the resulting nesSwitcha to YFP with a nuclear localization sequence
47. An
RFP-histone fusion (HTA2) was constitutively expressed in the same yeast cells to act as a
nuclear marker (Fig. 2.5a). YFP co-localized with RFP in the nucleus in the absence of
Keya-BFP, but upon expression of Keya-BFP the YFP fluorescence becomes more
cytosolic, likely due to uncaging of the nuclear export signal (Fig. 2.5b; Fig 2.15c, d).
Next we used nesLOCKR to control the nuclear localization of synTF to modulate its
activation of the pSynTF promoter. Using the dual-induction system, we expressed
synTF-RFP-nesSwitcha and Keya-BFP in the same cell as a pSynTF-YFP reporter, and
observed that induction of Key caused a 33% decrease in YFP signal, indicating successful
activation of nesLOCKR and exclusion of synTF from the nucleus (Fig. 2.5c; Fig 2.15e).
Together, these results demonstrate our ability to cage different functional peptide motifs
in live cells, highlighting the modularity and utility of LOCKR.
2.8 Conclusions
The design of tunable and generalizable protein switches is a considerable advance for de
novo protein design. In the Switchable LOCKR system described here, a designed key
added in trans induces a large conformational change in a designed cage that unlocks
protein function. We demonstrate the power and generality of LOCKR by caging three
distinct functions: in vitro, the proapoptotic peptide Bim binding to Bcl2, and in cells,
protein degradation mediated by the cODC degron and protein localization via a nuclear
export sequence. The modularity and hyperstability of de novo designed proteins enables
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tuning of Switch activation over a broad dynamic range by modulating the strength of the
competing Cage-Key and Cage-Latch interfaces. Moving forward, LOCKR provides a
general approach for controlling function that should be applicable to a wide range of
proteins and synthetic biology challenges.
It is instructive to compare LOCKR to regulatory systems in nature that utilize
autoinhibition and efforts to co-opt those systems for engineered protein switches.
Activation of apoptosis by the pro-apoptotic proteins Bak and Bax can be triggered by
displacement of auto-inhibitory interactions48, analogous to Key activation in LOCKR.
Actin nucleation is modulated by N-WASP, which has an autoinhibited actin nucleating
Arp2/3 binding domain that is released upon binding to the activators Cdc42 and PIP236.
A number of proteins, including N-WASP, have been repurposed to control non-cognate
functions in a Switchable, inducible manner49,50, but the LOCKR system has several
advantages. First, LOCKR is a universal platform to cage and then activate functionalities
at will ranging from inducible activation of high-affinity protein-protein interactions to
controlled degradation or localization of an attached cargo. Second, for any functional
modality, many cargoes can be regulated: here we couple key-induced LOCKR-gated
degradation to fluorescent protein levels both directly through fusion and indirectly
through fusion to an activating transcription factor; kinases can also be controlled in the
same way (see accompanying paper). Strategies that rely on repurposing natural proteins
have modularity and tunability limited by the evolved functions and ligands of these
existing proteins, whereas altering the affinities of LOCKR components is tunable based on
simple design principles that are generally irrespective of the functional modality or
application. Our use of a toehold for tuning helical displacement is reminiscent of DNA
strand displacement technology51,52, but unlike nucleic acid based approaches such as,
genetic toggles citeGardner2000-cc, or riboswitches53,54 (which have largely focused on
controlling transcription), LOCKR systems can be readily integrated with the many
diverse processes controlled by proteins. Viewed in this light, LOCKR brings to proteins
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the programmability of DNA switching technology, with the added advantages of tunability
and flexibility over rewired natural protein systems, and ready interfacing with biological
machinery over DNA nanotechnology. More generally, the domain of sophisticated
environmentally sensitive and Switchable function no longer belongs exclusively to
naturally occurring proteins.
2.9 Methods
PCR mutagenesis and isothermal assembly
All primers for mutagenesis were ordered from Integrated DNA Technologies (IDT).
Mutagenic primers were designed to anneal >18bp on either side of the site for mutagenesis
with the desired mutation encoded in the primer. PCR was used to create fragments
upstream and downstream of the mutation site with >20bp overlap with the desired pET
vector. The resulting amplicons were isothermally assembled into either pET21b, pET28b,
or pET29b restriction digested with XhoI and NdeI and transformed into chemically
competent E. coli XL1-Blue cells. Monoclonal colonies were sequenced with Sanger
sequencing. Sequence verified plasmid was purified using Qiagen miniprep kit and
transformed into chemically competent E. coli BL21(DE3)Star, BL21(DE3)Star-pLysS cells
(Invitrogen), or Lemo21(DE3) cells (NEB) for protein expression.
Synthetic gene construction
Synthetic genes were ordered from Genscript Inc. (Piscataway, NJ, USA) and delivered in
pET 28b+, pET21b+, or pET29b+ E. coli expression vectors, inserted at the NdeI and
XhoI sites of each vector. For pET28b+ constructs, synthesized DNA was cloned in frame
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with the N-terminal hexahistidine tag and thrombin cleavage site and a stop codon was
added at the C-terminus. For pET21b+ constructs, a stop codon was added at the
C-terminus such that the protein was expressed with no hexahistidine tag. For pET29b+
constructs, the synthesized DNA was cloned in frame with the C-terminal hexahistidine
tag. Plasmids were transformed into chemically competent E. coli BL21(DE3)Star,
BL21(DE3)Star-pLysS cells (Invitrogen), or Lemo21(DE3) cells (NEB) for protein
expression.
Bacterial protein expression and purification
Starter cultures were grown in Lysogeny Broth (LB) or Terrific Broth II (TBII) overnight
in the presence of 50 µg/mL carbenicillin (pET21b+) or 30 µg/mL (for LB) to 60 µg/mL
(for TBII) kanamycin (pET28b+ and pET29b+). Starter cultures were used to inoculate
500 mL of Studier TBM-5052 autoinduction media containing antibiotic and grown at 37
℃ for 24 hours. Cells were harvested by centrifugation at 4000 rcf for 20 minutes at 4 ℃
and resuspended in lysis buffer (20 mM Tris, 300 mM NaCl, 20 mM Imidazole, pH 8.0 at
room temperature), then lysed by microfluidization in the presence of 1 mM PMSF.
Lysates were cleared by centrifugation at 24,000 rcf for at least 30 minutes at 4 ℃.
Supernatant was applied to Ni-NTA (Qiagen) columns pre-equilibrated in lysis buffer. The
column was washed twice with 15 column volumes (CV) of wash buffer (20 mM Tris, 300
mM NaCl, 40 mM Imidazole, pH 8.0 at room temperature), followed by 15 CV of high-salt
wash buffer (20 mM Tris, 1 M NaCl, 40 mM Imidazole, pH 8.0 at room temperature) then
15 CV of wash buffer. Protein was eluted with 20 mM Tris, 300 mM NaCl, 250 mM
Imidazole, pH 8.0 at room temperature. Proteins were further purified by gel filtration
using FPLC and a SuperdexTM 75 Increase 10/300 GL (GE) size exclusion column,
pooling fractions containing monomeric protein.
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Size-exclusion Chromatography, Multi-Angle Light Scattering
(SEC-MALS)
SEC-MALS experiments used a SuperdexTM 75 Increase 10/300 GL (GE) size exclusion
column connected to a miniDAWN TREOS multi-angle static light scattering and an
Optilab T-rEX (refractometer with EXtended range) detector (Wyatt Technology
Corporation, Santa Barbara CA, USA). Protein samples were injected at concentrations of
3-5 mg/mL in TBS (pH 8.0). Data was analyzed using ASTRATM (Wyatt Technologies)
software to estimate the weight average molar mass (Mw) of eluted species, as well as the
number average molar mass (Mn) to assess monodispersity by polydispersity index (PDI)
= Mw/Mn.
Circular dichroism (CD) measurements
CD wavelength scans (260 to 195 nm) and temperature melts (25 to 95 ℃) were measured
using an AVIV model 420 CD spectrometer. Temperature melts monitored absorption
signal at 222 nm and were carried out at a heating rate of 4 ℃/min. Protein samples were
at 0.3 mg/mL in PBS pH 7.4 in a 0.1 cm cuvette. Guanidinium chloride (GdmCl)
titrations were performed on the same spectrometer with an automated titration apparatus
in PBS pH 7.4 at 25 ℃, monitored at 222 nm with protein sample at 0.03 mg/mL in a 1cm
cuvette with stir bar. Each titration consisted of at least 40 evenly distributed
concentration points with one minute mixing time for each step. Titrant solution consisted
of the same concentration of protein in PBS + GdmCl. GdmCl concentration was
determined by refractive index.
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Small angle X-ray scattering (SAXS)
Samples were exchanged into SAXS buffer (20 mM Tris, 150 mM NaCl, 2% glycerol, pH
8.0 at room temperature) via gel filtration. Scattering measurements were performed at
the SIBYLS 12.3.1 beamline at the Advanced Light Source. The X-ray wavelength (λ) was
1.27 A˚ and the sample-to-detector distance of the Mar165 detector was 1.5 m,
corresponding to a scattering vector q (q = 4pi ∗ sin(θ/λ) where 2θ is the scattering angle)
range of 0.01 to 0.59 A˚−1. Data sets were collected using 34 0.2 second exposures over a
period of 7 seconds at 11 keV with protein at a concentration of 6 mg/mL. Data were also
collected at a concentration of 3 mg/mL to determine concentration-dependence; all
presented data was collected at the higher concentration as no concentration-dependent
aggregation was observed. Data from 32 exposures was averaged separately over the
Gunier, Parod, and Wide-q regions depending on signal quality over each region and frame.
The averages were analyzed using the ScA˚tter software package to analyze data and report
statistics (Table 2.1). FoXS was used to compare design models to experimental scattering
profiles and calculate quality of fit (X) values. The hexahistidine tags and thrombin
cleavage sites on the N-termini of LOCKR proteins were modeled using Rosetta Remodel
so that the design sequence matched that of the experimentally tested protein. To capture
conformational flexibility of these residues, 100 independent models were generated,
clustered, and the cluster center of the largest cluster was selected as a representative
model for FoXS fitting without bias.
GFP pulldown assay
His-tagged LOCKR was expressed per the above protocol from pET28b+ while the Key
was expressed fused to superfolder GFP (sfGFP) without a his-tag in pET21b+. The
his-tagged LOCKR was purified to completion and dialyzed into TBS (20 mM Tris, 150
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mM NaCl, pH 8.0 at room temperature); the Key-GFP remained as lysate for this assay.
100 µL LOCKR at >1 µM was applied to a 96-well black Pierce Nickel Coated Plate
(ThermoFisher) and incubated at room temperature for 1 hour. Sample was discarded
from the plate and washed 3x with 200 µL TBST (TBS + 0.05% Tween-20). 100 µL of
lysate containing Key-GFP was added to each well and incubated at room temperature for
1 hour. Sample was discarded from the plate and washed 3x with 200 µL TBST (TBS +
0.05% Tween-20). The plate was washed 1x with TBS, and 100 µL of TBS was added to
each well. sfGFP fluorescence was measured on a Molecular Devices SpectraMax M5 plate
reader or BioTek Synergy Neo2 plate reader; fluorescence was measured at 485 nm
excitation and 530 nm emission, with a bandwidth of 20 nm for excitation and emission.
Bio-Layer Interferometry (BLI)
BLI measurements were made on an Octet RED96 System (ForteBio) with streptavidin
(SA) coated biosensors and all analysis was performed within ForteBio Data Analysis
Software version 9.0.0.10. Assays were performed with protein diluted into HBS-EP+
Buffer from GE (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.05% v/v Surfactant P20,
0.5% non-fat dry milk, pH 7.4 at room temperature). Biotinylated Bcl2 was loaded onto
the SA tips to a threshold of 0.5 nm programmed into the machine’s protocol. Baseline was
obtained by dipping the loaded biosensors into HBS-EP+ buffer; association kinetics were
observed by dipping into wells containing defined concentrations of LOCKR and Key, then
dissociation kinetics were observed by dipping into the buffer used to obtain the baseline.
Kinetic constants and response at equilibrium were computed by fitting a 1:1 binding
model.
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Construction of DNA circuits
Hierarchical golden gate assembly was used to assemble plasmids for yeast strain
construction using the method in Lee et al.55. Individual parts had their BsaI, BsmBI, and
NotI cut sites removed to facilitate downstream assembly and linearization. Parts were
either generated via PCR or purchased as gBlocks from IDT. These parts were assembled
into transcriptional units (promoter-gene-terminator) on cassette plasmids. These cassettes
were then assembled together to form multi-gene plasmids for insertion into the yeast
genome.
Yeast strains and growth media
The base S. cerevisiae strain used in all experiments was BY4741 (MATa his3∆1 leu2∆0
met15∆0 ura3∆0). All yeast cultures were grown in YPD media (10 g/L Bacto Yeast
Extract, 20 g/L Bacto peptone, 20 g/L dextrose) or synthetic complete medium (SDC) (6.7
g/L Bacto-yeast nitrogen base without amino acids, 2 g/L complete supplement amino acid
mix, 20 g/L dextrose). Selection of auxotrophic markers (URA3, LEU2, and/or HIS3) was
performed on synthetic complete medium with the appropriate dropout amino acid mix.
Estradiol and Progesterone induction
Yeast strains were grown overnight by picking a single colony from a plate into YPD
media. Saturated culture was diluted 1:500 in fresh SDC and aliquoted into individual
wells of a 2 mL 96 well storage block (Corning) for a three hour outgrowth at 30◦C and 900
RPM in a Multitron shaker (Infors HT). Estradiol (Sigma-Aldrich) and progesterone
(Fisher Scientific) were prepared at a 10x concentration by making the appropriate
dilutions into SDC from a 3.6 mM estradiol and 3.2 mM progesterone stock solution. After
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the three hour outgrowth, 50 µl of estradiol and progesterone inducer were added to the 96
well block in the appropriate combinations and the block was returned to the shaker. Flow
cytometry measurement was performed after six hours of incubation for all experiments,
except for those involving synTF or dCas9, which was allowed to incubate for 12 hours due
to the additional transcriptional step in the system.
Mammalian Cell Culture and Lentiviral Transduction
HEK293T cells were maintained in DMEM (Dulbecco’s Modified Eagle Medium, Gibco)
supplemented with 10% Fetal Calf Serum (SAFC) and 1% Antibiotic-Antimycotic and
passaged every 3 days. Pantropic VSV-G pseudotyped lentivirus was produced via
transfection of Lenti-X 293T cells (Clontech 11131D) with a custom pHR SIN:CSW
transgene expression vector and the viral packaging plasmids pCMVdR8.91 and pMD2.G
using Fugene HD (Promega). At 48 hr, viral supernatant was harvested and the HEK293T
cells were exposed to the virus for 24 hr. Transductions were performed in triplicate.
Description of automated flow cytometry and continuous culture
system
Hardware We adapted an existing automated experimental platform56 to perform
variable concentration small molecule induction and long-term culturing. Yeast cultures
were grown in 50 mL optically clear conical tubes (Falcon) that were held in eight custom
temperature-controlled, magnetically stirred chambers. Liquid handling was accomplished
using a 14 position stream selector (VICI Cheminert) and two syringe pumps (Cavro
XCalibur Pump, TECAN) of a BD High-Throughput Sampler. Commands to the HTS
were controlled using LABVIEW 2013. This setup allowed for periodic sampling and
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dilution of individual cultures. Each sampling period consisted of three main steps: 1) send
sample to flow cytometer for measurement, 2) extract culture and send to waste, and 3)
replenish culture with fresh media at desired hormone concentration. Each sampling period
can be designated to either induce cultures to a new higher hormone concentration or to
maintain desired hormone concentration. A sampling frequency of 24 minutes and a
dilution volume of 3 mL were used.
Yeast culture Yeast strains were grown overnight by picking a single colony from a plate
into YPD media. Saturated culture was diluted 1:200 into fresh SDC. Cultures were grown
for 2 hours in glass tubes at 30◦C and 250 RPM in a Innova 44 shaker (New Brunswick).
Cultures were then diluted to 0.01 OD600 in fresh SDC and aliquoted into individual 50 mL
optically clear conical tubes (Falcon) at a total volume of 30 mL YPD. Another one hour
outgrowth was performed in bioreactors with magnetically-controlled stir bars at 30◦C. All
SDC media was supplemented with 5,000 U/mL Penicillin Streptomycin (Thermo-Fisher).
Estradiol and progesterone induction to test degronLOCKR dynamics A 1X
concentration was determined by the highest desired hormone concentration at which to
test strains (30 nM E2 and 50 nM Pg, respectively). A solution of E2 and SDC media was
created at a 10X concentration to bring pre-induced cultures to a desired concentration in
one sampling period. A second solution of Pg and SDC media was created at a 10X
concentration to induce Key expression after degSwitch-YFP expression reached
steady-state. SDC media was prepared at three different concentrations of hormone: (1)
10X E2/no Pg, (2) 1X E2/no Pg, (3) 1X E2/10X Pg, and (4) 1X E2/1X Pg. After a one
hour outgrowth in bioreactors (t=-6 hr), the first induction was performed to achieve E2
concentration by extracting 3 mL from all cultures and replenishing with (1). After E2
induction, sampling proceeded as described above (see Hardware). All sampling periods
following the first induction time point included sending a sample to the cytometer for
measurement, extracting 3 mL from all cultures, and replenishing cultures with (2). During
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the second induction time point (t=0 hr), cultures were induced with (3) to activate Key
expression. This induction was followed by the same procedure as the first induction,
except that hormone concentrations were maintained by (4). Controls (no activated Key
expression) did not undergo a second induction and, instead, continued to be replenished
by (2).
Flow cytometry
Yeast experiments Analysis of fluorescent protein expression was performed using a BD
LSRII flow cytometer (BD Biosciences) equipped with a high-throughput sampler. Yeast
cultures were diluted in TE before running through the instrument to obtain an acceptable
density of cells. YFP (Venus) fluorescence was measured using the FITC channel, RFP
(mScarlet) was measured using the PE-Texas Red channel, and BFP (mTagBFP2) was
measured using the DAPI channel. For steady-state measurements, 5,000-10,000 events
were collected per sample. For dynamic measurements, 2,000-10,000 events were collected
per sample. Fluorescence values were calculated as the height (H) measurement for the
appropriate channel and normalized to cell size by dividing by side scatter (SSC-H). All
analysis of yeast flow cytometry data was performed in Python 2.7 using the package
FlowCytometryTools v0.5.0 and custom scripts.
HEK293T experiments Analysis of fluorescent protein expression was performed using a
BD Fortessa flow cytometer (BD Biosciences) equipped with a high-throughput sampler.
Cells were harvested and washed twice in PBS before running through the instrument in
PBS+5% FBS. RFP (mCherry) fluorescence was measured using the PE-CF594 channel
and BFP (tagBFP) was measured using the BV 421 channel. 50,000 events were collected
per sample. Live cells were gated according to FSC-A and SSC-A, and singlets were gated
according to SSC-A and SSC-H. Analysis of HEK293T flow cytometry data was performed
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using FlowJo v10.
Fluorescence microscopy
Saturated culture was diluted 1:100 in fresh SC media followed by a 3 hour outgrowth at
30◦C with shaking at 700 RPM in a Multitron shaker (Infors HT). Estradiol
(Sigma-Aldrich) and progesterone (Fisher Scientific) were prepared at a 20x concentration
by making the appropriate dilutions into SC media from a 3.6 mM estradiol and 3.2 mM
progesterone stock solution. Cells were induced with estradiol and/or progesterone at a
final concentration of 200 µM and 250 µM, respectively. After 8 hours of growth, cells were
resuspended in 1x PBS and imaged on a Zeiss Axio Observer Z1 microscope with X-Cite
Series 120 fluorescent lamp and Hamamatsu Orca-Flash 4.0 Digital Camera.
Structural visualization and figures
All structural images for figures were generated using PyMOL57.
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Figure 2.1: Design of the LOCKR System
a, The Switch, composed of a Cage (cyan) and Latch (blue) with a functional motif
(orange), has a thermodynamic transition to the open state able to bind Key (green) or
Target (yellow). b, Numerical solutions of the model in (a) for different values of KLT (1
nM, left; 50 nM, right) and Kopen (0.1, red; 0.001, orange; 1e-5, green; 1e-7, blue; 1e-9,
purple) with KCK fixed at 1 nM. c, Conversion of 5L6HC3 to monomeric frameworks. In
LOCKR (right), the double mutant V223S/I238S allows the Key to bind. d, Guanidinium
chloride denaturation of trimer (dark blue), monomer (cyan), truncated five-helix
framework (red), and LOCKR (green) monitoring mean residue ellipticity (MRE) at 222
nm. Repeated 3 times with similar results. e, Small-angle X-ray scattering (SAXS) Kratky
plots for the monomeric frameworks are similar to that of the input trimer, with the
greatest deviation for the five-helix framework. Colors continued from (d). f, Key-GFP was
added to monomeric frameworks immobilized onto a plate via a hexahistidine tag; after
washing, binding was measured by GFP fluorescence (mean of n=3 technical replicates,
error bars indicate s.d).
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Figure 2.2: BimLOCKR design and activation.
a, Bio-layer interferometry (BLI) measurement of BimLOCKR (250 nM) binding to
immobilized Bcl2 in the presence and absence of 5 µM Key. Bim is tightly caged in the
absence of Key; introduction of the toehold (right) allows key to outcompete Latch leading
to Bcl2 binding. b, BLI measurement of Key-dependent binding of 250 nM BimLOCKR to
Bcl2. Purple is 3 µM Key, then a three-fold dilution of the Key through blue, cyan, green,
yellow, and orange; control without Key in red. c, Bcl2 binding by BimLOCKR as a
function of Key concentration. BLI data was fit for the different length Keys to obtain
equilibrium sensor response. BLI experiments (b,c) repeated three times with similar
results. d, Bcl2 binding of BimSwitcha (dark blue), BimSwitchb (blue), and BimSwitchc
(light blue) designs in response to cognate Key, measured by BLI and normalized to Rmax.
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Repeated twice with similar results. e, Bcl2 binding in BLI experiments for each Switch at
250 nM, Key at 5 µM ; data points are average Rmax of two replicates.
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Figure 2.3: Testing functionality of degronLOCKR in live cells.
a, Dual-induction system used in S. cerevisiae to test degronLOCKR function. b, Dose
response of YFP-degronSwitcha and Keya-BFP at 50nM E2 as a function of Pg induction.
YFP, normalized to no Pg; BFP normalized to max Pg. Lines connecting data are a guide
to the eye. c, Dynamics of degronLOCKR using an automated flow cytometry platform.
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Cells were grown to steady-state at 50nM E2 then induced with Pg to express Keya-BFP
at t0hrs. Lines represent moving average taken over three data points. d, Dose response of
orthogonal degronLOCKRs as a function of Pg. YFP-degronSwitcha and
RFP-degronSwitchc were expressed constitutively in the same cell with either Keya-BFP
(left) or Keyc-BFP (right) expressed using Pg. YFP-degronSwitcha, RFP-degronSwitchc
and either Keya-BFP or Keyc-BFP were normalized to no Pg (RFP, YFP) or max Pg
(BFP). Lines connecting data are a guide to the eye. e, Asymmetric RFP-degronSwitcha
was expressed in HEK293T cells with and without Key. Flow cytometry distribution of
RFP fluorescence for a representative sample indicates decreased RFP expression in the
presence of Key. Geometric mean of RFP expression is quantified in the bar plot. Data in
all panels represent mean ± s.d. of three biological replicates.
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Figure 2.4: Controlling gene expression using degronLOCKR in yeast.
a, (Left) Dual-induction system used to determine the effect of degronLOCKRa on a
synthetic transcription factor (synTF). (Right) Dose response of YFP,
SynTF-RFP-degronSwitcha and Keya-BFP-NLS at 31.25nM E2 as a function of Pg
induction, normalized to no Pg (YFP, RFP) or max Pg (BFP). b, (Left) Dual-induction
system used to determine the effect of degronLOCKRa on a dCas9-VP64 targeted to the
pTet7x promoter. (Right) Dose response of YFP, dCas9-VP64-RFP-degronSwitcha and
Keya-BFP-NLS at 31.25 nM E2 as a function of Pg induction, normalized to no Pg (YFP,
RFP) or max Pg (BFP). Data in all panels represent mean ± s.d. of three biological
replicates. Lines connecting data are a guide to the eye.
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Figure 2.5: Controlling protein localization using nesLOCKR in yeast.
a, Key-induced nuclear export of NLS-YFP-nesSwitcha. The nucleus is marked by the
histone HTA2-RFP. b, Fluorescence microscopy showing co-localization of
NLS-YFP-nesSwitcha (green) with nuclear HTA2-RFP (red) fluorescence when no
Keya-BFP is expressed (top), compared to a more diffuse NLS-YFP-nesSwitcha fluorescent
signal observed outside of the nucleus when Keya-BFP is expressed (bottom). Images
shown are representative of n=3 biological replicates. c, (Left) Dual-induction system used
to determine the effect of nesLOCKRa on a synthetic transcription factor (synTF). (Right)
Dose response of YFP, synTF-RFP-nesSwitcha and Keya-BFP at 31.25 nM E2 as a
function of Pg induction, normalized to no Pg (RFP, YFP), maximum Pg (BFP). Data
represent mean ± s.d. of three biological replicates. Lines connecting data are a guide to
the eye.
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2.13 Extended Data Figures
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Figure 2.6: Biophysical data from LOCKR design.
a. Size Exclusion Chromatography for the Monomer, Truncation, and LOCKR designs on
Superdex 75. Peaks indicated by vertical dashed lines represent monomeric protein used in
downstream characterization and functional assays. SEC repeated three times with similar
results. b. Circular dichroism spectroscopy to determine protein stability upon heating and
chemical denaturant, guanidinium chloride. Top row: full wavescan at 25◦C (blue), 75◦C
(orange), 95◦C (red), then cooled to 25◦C (cyan). Middle row: guanidinium chloride melts
also shown overlapped in Figure 2.1d. Bottom row: fraction folded was converted to
equilibrium constant, then to ∆Gunfolding value. The linear unfolding region, marked by
vertical lines in middle row, was fit to determine the ∆Gunfolding for each design. Repeated
four times with similar results. c. SAXS spectra (black) referenced in Figure 2.1e fit to
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Rosetta design models (red) using FoXS with chi-values referenced in the upper right.
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Figure 2.7: GFP Plate assay to find mutations for LOCKR.
Different putative LOCKR constructs were adhered via 6x-His tag to a Ni coated 96-well
plate, Key-GFP was applied, and excess washed. Resulting mean fluorescence values
represent Key-GFP bound to LOCKR constructs. The truncation was used as a positive
control, since the Key binds to the open interface. The monomer as a negative control
since it does not bind the Key. Error bars represent the standard deviation of three
technical replicates, because Key-GFP was not purified from bacterial lysate leading to
minor technical variability.
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Gen 1: aBcl2 - M-QEL-DK-RAASLQ-NGD-FYA-LR-L
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Figure 2.8: Caging Bim-related sequences.
a. Three Bcl2 binding sequences were grafted onto the Latch. aBcl2 is a single helix from a
designed Bcl2 binder (pdb: 5JSN) where non Bcl2-interacting residues were reverted back
to the standard LOCKR Latch sequence, shown as dashes. pBim is the partial Bim
sequence where only Bcl2-interacting residues are grafted onto the Latch. Bim is the full
consensus sequence of the BH3 domain. b. LOCKR (left) with the Latch in dark blue.
The helical Bim sequence is taken from the Bim/Bcl2 interaction and grafted onto the
Latch c. Left: Bcl2 (tan) binding to Bim (orange) from pdb:2MV6 with pBim residues
shown as sticks. Center: a well caged graft where important binding residues are caged.
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Right: a poor graft where Bcl2 binding residues are exposed and polar surface residues are
against the Cage interface. d. Tuning BimLOCKR. aBcl2, pBim, and Bim were caged to
varying degrees of success. Early versions of the switch, with aBcl2 and pBim did not
efficiently cage Bcl2 binding in the off state. They also only weakly bound the Key leading
to small dynamic range. The Cage and Key was extended by 5, 9, and 18 residues in an
attempt to provide a larger interface to tightly hold the Latch in the off state and provide a
larger interface for Key binding to increase the dynamic range of activation. Mutations on
the Latch, identified in Figure 2.7, and providing toeholds for Key binding were the two
strategies employed to tune the switch. In graphs, “off” refers to 250-310 nM switch an
absence of Key while “on” refers to excess Key added. The height of the bar graph shows
the Req as measured by Bio-layer interferometry.
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Figure 2.9: Validation of model in Figure 2.6a.
a. Measurement of Bim:Bak affinity. Bio-layer interferometry (BLI) at three
concentrations gives on and off rates for Bim:Bak binding, yielding the constants shown on
right. Mean shown with standard deviation of four technical replicates to account for
variablility in drift on the BLI instrument. b. BLI measurement of BimLOCKRa (400 nM)
binding to Bcl2 (gold), BclB (yellow), and Bak (lighter yellow - BimLOCKR at 1 µM) as
Key is added to solution. Normalized due to differences in Rmax for Bcl2 and BclB on the
tip. c) BLI measurement of BimLOCKRa binding to Keya immobilized on the tip. Open
circles are with no Bcl2 present, gold points are with Bcl2 present at 500 nM.
38
cODC Full:    LPMSCAQES
cODC noPro:   L-MSCAQES
cODC CA_only: ----CA---
b
a
Full noPro
c
d
Figure 2.10: Caging cODC sequences.
a. Three variations of the cODC degron to Cage. Variations meant to tune Kopen by
removing the destabilizing proline (noPro) and minimizing mutations to the Latch (CA
only). b) Predicted models of the full and noPro cODC sequences (orange) threaded onto
the Latch (dark blue). Thread position chosen such that the cysteine residue needed for
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degradation is sequestered against the Cage (light blue). Proline highlighted in red in the
full cODC mutated to an isoleucine in the noPro variant. c. Comparing the stability of
YFP fused to cODC variants caged in Switcha to an empty Switcha and to bimSwitcha.
The dual-inducible system from Fig 2.3a was used to express the various YFP-Switcha
fusions (solid lines and dots) via pGAL1 and E2, and Keya-BFP via pZ3 and Pg. YFP
(Venus) alone, YFP fused to the WT cODC (cODC) or YFP fused to the proline removed
cODC (cODC noPro), were also expressed using pGal1 and E2 (dashed lines). Cells were
induced with a saturating dose of E2 (50 nM) and Pg was titrated in from 0-200 nM.
Fluorescence was measured at steady-state using a flow cytometer; data represent mean ±
s.d. of three biological replicates. Lines connecting data are a guide to the eye. A moderate
decrease in YFP fluorescence was observed as a function of Pg for the full cODC variant,
whereas only a small decrease was observed for the proline removed and CA only. No
decrease in fluorescence was observed as a function of Key induction for YFP alone, empty
Switcha, or bimSwitcha. d) Tuning toehold lengths of degronLOCKRa. The dual-inducible
system from Fig 2.3a was used to express the various YFP-Switcha fusions via pGal1 and
E2, and Keya-BFP via pZ3 and Pg. YFP fused to the proline-removed cODC (cODC no
Pro) was also expressed using pGal1 and E2 (dashed line). Cells were induced with a
saturating dose of E2 (50 nM) and Pg was titrated in from 0-200 nM. Fluorescence was
measured at steady-state using a flow cytometer; data represent mean ± s.d. of three
biological replicates. Lines connecting data are a guide to the eye. (Left) cODC variants
alone to show dynamic range of Full cODC. (Right) Extending toehold on proline-removed
version from 9 to 12 and 16aa. Proline-removed with 12aa toehold shows the greatest
dynamic range of all the Switches tested.
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Figure 2.11: YFP (a) and BFP (b) expression corresponding to Figure 2.3b.
0-50nM E2 and 0-200nM Pg were used to induce expression of YFP-degronSwitcha and
Keya (Full-length or truncated)-BFP, respectively. Fluorescence was measured at
steady-state using a flow cytometer. Heatmaps depict mean fluorescence and are a
representative sample of three biological replicates. E2 dose (50nM) depicted in Fig 3b is
indicated with the black rectangle on the heatmaps. YFP fluorescence was normalized to
the maximum fluorescence (50nM E2, 0nM Pg). BFP expression was not dependent on
expression of the Switch, suggesting the Key does not co-degrade with the Switch.
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Figure 2.12: degronLOCKRa−d orthogonality.
All combinations of pTDH3-YFP-degronSwitch and pTDH3-Key-CFP were tested.
Fluorescence was measured at steady-state using a flow cytometer. YFP fluorescence was
averaged across three biological replicates. Percentage degradation was calculated by
subtracting the mean YFP-degronSwitch fluorescence with the given Key-CFP coexpressed
from the YFP-degronSwitch fluorescence without any Key expressed and normalizing by
the YFP-degronSwitch fluorescence without any Key expressed. degronSwitcha is activated
strongly by Keya and weakly by Keyb. degronSwitchc is activated strongly by Keyc and
weakly by Keyb. Because degronSwitcha and degronSwitchc are not activated by Keyc and
Keya respectively, we consider these two to be an orthogonal pair.
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Figure 2.13: Comparison of different degronSwitch variants in HEK293T cells.
Fluorescence of RFP-degronSwitch variants in the presence and absence of Key-BFP were
measured using flow cytometry. Original symmetric design was compared against a new
asymmetric design. Two toehold lengths were tested for each variant. Data in bar graph
represents geometric mean ± s.d. of three biological replicates. Histograms are depicted for
a representative sample. Asymmetric cage with a t8 toehold demonstrates the largest
dynamic range.
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Figure 2.14: YFP and RFP expression for synTF (a) and dCas9-VP64 (b) assay correspond-
ing to Fig 2.4 as a function of E2 (0-125 nM) and Pg (0-100 nM).
YFP fluorescence represents transcriptional output of either synTF or dCas9-VP64 and
RFP fluorescence represents fluorescence of either synTF or dCas9-VP64. Fluorescence was
measured at steady-state using flow cytometry. Heatmaps depict mean fluorescence and
are a representative sample of three biological replicates. E2 dose (31.25nM) depicted in
Fig 2.5 is indicated with the black rectangle on the heatmaps.
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Figure 2.15: Design and characterization of nesLOCKR.
a. NES used in this report. b. The NES (orange) caged on the helical Latch (dark blue,
cartoon) with hydrophobic residues sequestered against the Cage (light blue, surface) c.
(Left) Schematic of cytosolic YFP-nesSwitcha and Key-BFP with nuclear marker
HTA2-RFP. (Right) YFP fluorescence shows the expected cytosolic distribution when
YFP-nesSwitcha is expressed with no NLS (left) but punctae of YFP fluorescence is
observed when both YFP-nesSwitcha and Key-BFP are expressed in the cytosol, which we
assume is due to aggregation of the nesSwitcha. Key-BFP fluorescence is co-localized to
YFP-nesSwitcha fluorescence. d) (Left) Schematic of NLS-YFP-nesSwitcha with
Key-BFP-NLS with nuclear marker HTA2-RFP. (Right) YFP-nesSwitcha is localized to the
nucleus when expressed with the strong (SV40) NLS. When Key-BFP is expressed with a
moderately strong NLS, the same pattern of cytosolic YFP punctae formation is observed
as when Key-BFP is expressed without a NLS (Figure 2.5b), indicating that uncaging of
the NES is independent of NLS on Key-BFP localization. Key-BFP-NLS fluorescence is
co-localized to NLS-YFP-nesSwitcha fluorescence e) YFP and RFP expression for synTF
assay corresponding to Fig 2.5c as a function of E2 (0-125 nM) and Pg (0-500 nM).
Fluorescence was measured at steady-state using flow cytometry. Heatmaps depict mean
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fluorescence and are a representative sample of three biological replicates. E2 dose
(31.25nM) depicted in Fig 2.5c is indicated with the black rectangle on the heatmaps.
2.14 Supplementary Information
2.14.1 Thermodynamic LOCKR Model
The thermodynamic model in Figure 2.1a, main text, illustrates three free parameters for
five equillibrea; one that defines the equillibrium of latch opening, one that defines the
dissociation constant of the key, and one that defines the dissociation constant of the target.
These define three equations that relate the concentrations of all species (open or closed
Switch, Key, Target, Switch:Key, Switch:Target, and Switch:Key:Target) at equilibrium.
Kopen =
[Switchopen]
[Switchclosed]
(2.1)
KCK =
[Switchopen][Key]
[Switch: Key]
=
[Switch: Target][Key]
[Switch: Key : Target]
(2.2)
KLT =
[Switch: Key][Target]
[Switch: Key : Target]
=
[Switchopen][Target]
[Switch: Target]
(2.3)
The total amount of each component (Switch, Key, and Target) is also constant, as defined
by experimental conditions, and constrains the values of each species at equilibrium. This
introduces the following equations to the model.
[Switch]total = [Switchopen] + [Switchclosed] + [Switch: Key]+
[Switch: Target] + [Switch: Key : Target]
(2.4)
[Key]total = [Key] + [Switch: Key] + [Switch: Key : Target] (2.5)
[Target]total = [Target] + [Switch: Target] + [Switch: Key : Target] (2.6)
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These six equations were solved using the python module sympy.nsolve()58 to find the
concentration of each species at equilibrium given the six constants (three equilibrium
constants, three total concentrations). To compute fraction bound for relevant figures, the
total concentration of Switch:Target and Switch:Key:Target was extracted from this
solution, divided by the total Target present, and plotted for the corresponding figures.
Code for this model is contained in LOCKR.py, see Code Availability.
2.14.2 Grafting Functional Sequences onto LOCKR using
Rosetta
Models of functional LOCKRs were made by grafting bioactive sequences (Bim, cODC,
nuclear export sequence; Table 2.2) onto the Latch. This design was performed using
RosettaScripts with the input file thread relax.xml (See Code Availability). A bash
script, thread switch.sh (See Code Availability), applied the design XML at every helical
register on the latch by passing script variables, sequence and threading position, into the
XML. The protocol uses two Rosetta movers, SimpleThreadingMover to change the amino
acid sequence on the latch, and FastRelax with default settings to find the lowest energy
structure given the mutations from the previous mover. Designs were selected by eye in
PyMol 2.0. High quality grafts had important binding residues interacting with the cage
and occluded the target as determined by crystal structure, if available (PDB ID: 2VM6 for
Bim:Bcl2). As a secondary consideration, good designs minimized the number of buried
unsatisfied hydrogen bonding residues. In limited cases for caging the cODC degron in
orthogonal LOCKR switches, a designed hydrogen bonding network residue was opted for
over a functional residue at the first or last residue.
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2.14.3 Rosetta Design of Orthogonal and Asymmetric LOCKR
The XML redesign c terminal helix parallel.xml (See Code Availability) was used to
redesign LOCKRa to orthogonal cage-key pairs using Rosetta59 with scorefunction
beta nov16. We extracted a model of the five-helix cage from the LOCKRa model and
used Rosetta’s BundleGridSampler module to generate an ensemble of backbones for new
latch geometries. The BundleGridSampler generates backbone geometry based on the
Crick expression for a coiled-coil60,61 and allows efficient, parallel sampling of a regular grid
of coiled-coil expression parameter values, which correspond to a continuum of peptide
backbone conformations. For each parametrically-generated latch conformation sampled,
the InterfaceByVector residue selector specified the interface of the cage and latch for
design of hydrogen bonding networks (HBNet)62 followed by Rosetta sidechain design.
Residues on the cage not selected by the residue selector were held constant to their
original LOCKR design residues. Hydrogen Bond networks were designed using
HBNetStapleInterface on the residues selected at the interface. The output contained
designs with two or three hydrogen bond networks which span the three helices that make
up the interface. Downstream design and filtering was performed according to previous
methods.62
Candidate orthogonal LOCKR designs were selected based on lacking unsatisfied buried
hydrogen bonding residues, the count of alanine residues as a proxy for packing quality,
and sequence dissimilarity as a metric to find most dissimilar polar/hydrophobic
patterning, to select for orthogonality. Unsatisfied hydrogen bonding atoms were filtered
out using the BuriedUnsatHbonds filter allowing no unsatisfied polar atoms according to
the filter’s metrics. Packing quality was determined by counting alanine residues at the
interface because high alanine count means poor interdigitation of residues. A maximum of
15 alanine residues were allowed in the entire three helix interface. Pairwise sequence
dissimilarity of every designed latch was scored with BLOSUM62 by aligning sequences
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using the Bio.pairwise2 package from BioPython63 as shown in seq alignment.py (See
Code Availability). Alignment was performed disallowing gaps within the sequence (using
large opening and extension penalties) which is analogous to a structural alignment of two
helices to find the most similar superposition based on hydrophobic-polar patterning. Each
score was subtracted from the maximum score to convert scores into a distance metric; the
most diverse sequences has the lowest BLOSUM62 score which converts to the largest
distance. The sequences were then clustered using HeirClust fromRMSD.py and clustered
with a cutoff of 170, resulting in 13 clusters. The center of each cluster was picked by
maximizing distance between the 13 centers selected. The 13 candidates were then filtered
by eye in PyMol 2.0 for unsatisfied hydrogen bonding atoms and qualitative packing
quality.
Further utilizing the Switcha scaffold in mammalian cells requires redesign to enhance
stable expression. The Switch scaffold contains amino acid sequence repeats leftover from
the original symmetric, homotrimeric design; the asymmetrized degronSwitch was designed
using Rosetta59 to identify asymmetric sequence changes in these repeated regions that are
compatible with the Switch scaffold structure to maintain overall topology and packing
interactions.
2.14.4 Calculation of degronLOCKR half-life
The half-life of degronLOCKR-induced degradation was calculated using two equations
that model the system before and after key induction:
dY FPcaged
dt
= α− (γ + βcaged) ∗ Y FPcaged (2.7)
dY FPuncaged
dt
= α− (γ + βuncaged) ∗ Y FPuncaged (2.8)
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where α is the YFP production rate, γ is the dilution rate, βcaged is the caged
degronLOCKR-mediated degradation rate (without key induction), and βuncaged is the
uncaged degronLOCKR-mediated degradation rate (with key induction). We expect that
βuncaged is a function of key concentration but here we will only consider the active
degradation rate at steady-state for a single key concentration. We first calculated γ as a
function of the measured growth rate and the dilution rate:
γ =
ln 2
Td
+
(
Ve
Vt
)
Ts
(2.9)
where Td is the doubling time of the culture, Ve is the volume removed during each
sampling, Vt is the total volume in each bioreactor, and Ts is the sampling period. To solve
for βcaged and α, we first found the solution to equation 2.7:
Y FPcaged(t) =
α
γ + βcaged
∗ (1− e−(γ+βcaged)∗t) (2.10)
When t = trise =
1
γ + βcaged
:
Y FPcaged(trise) = Y FPSS ∗ (1− e−1) = 0.63 ∗ Y FPSS (2.11)
where Y FPSS =
α
γ + βcaged
. We solved for βcaged by determining trise, which allowed
allowed us to calculate α using the steady-state YFP expression measurement before key
induction:
α = Y FPSS ∗ (γ + βuncaged) (2.12)
Using γ and α we were able to calculate βcaged. The degradation rate of the degronSwitch
(β) is a function of key concentration, but to simplify our calculation we were only
interested in determining uncaged degronLOCKR half-life at steady-state key
concentration. Thus we determined βuncaged using the steady-state of equation 2.8. The
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calculated half-life of uncaged degronLOCKR is equal to
ln 2
βuncaged
, or 24 minutes. The
half-life of caged degronLOCKR, or
ln 2
βcaged
, is equal to 310.6 minutes, indicating that
uncaging of degronLOCKR upon key induction increases degradation by over 10-fold. All
parameters summarized in Table 2.3.
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Table 2.2: Functional Peptides Designed Into LOCKR Switches
Name Sequence
aBcl2 - Designed Bcl2 Binder M-QEL-DK-RAASLQ-NGD-FYA-LR-L
pBim I---LR-IGD-F---Y
Bim EIWIAQELRRIGDEFNAYYA
cODC LPMSCAQES
cODC noPro L-MSCAQES
cODC CA only CA
NES LALKLAGLDIN
Table 2.3: Parameters used for degronLOCKR half-life calculation
Td 98.6min
Ve 3mL
Vt 30mL
Ts 24min
γ 0.007min−1
tf 108min
Y FPSS 1.29AU
βcaged 0.002AU ∗min−1
α 0.012AU ∗min−1
βuncaged 0.029AU ∗min−1
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Chapter 3
Modular and tunable biological
feedback control using a de novo
protein switch
3.1 Abstract
De novo designed proteins12,28,64 hold great promise as building blocks for synthetic
circuits, complementing the use of engineered variants of natural proteins65–68. One such
designer protein, degronLOCKR, is a switch that degrades a protein of interest in vivo
upon induction by a genetically encoded small peptide. Here, we leverage the plug-and
play nature of degronLOCKR to implement feedback control on both endogenous signaling
pathways and synthetic gene circuits. We first generate synthetic negative and positive
feedback in the yeast mating pathway via fusion of degronLOCKR to endogenous signaling
molecules, illustrating the simplicity with which this strategy can be used to rewire
complex endogenous pathways. We next benchmark degronLOCKR-mediated feedback
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control on a synthetic gene circuit43 to quantify its feedback capabilities and operational
range. The designer nature of degronLOCKR enables simple and rational modifications to
tune feedback behavior in both the synthetic circuit and the mating pathway. The ability
to engineer feedback control into living cells represents an important milestone for
achieving the full potential of synthetic biology69,70. More broadly, this work demonstrates
the large, but still untapped, potential of de novo protein design to generate tools that can
implement diverse functionalities in cells for biotechnology and therapeutic applications.
3.2 Introduction
degronLOCKR is based on LOCKR (Latching Orthogonal Cage Key pRoteins) technology,
and consists of the designer degronSwitch and key proteins. The degronSwitch is a six-helix
bundle that has the cODC degron71 embedded in the destabilized sixth helix (latch), which
is occluded via intramolecular interactions with the five-helix scaffold (cage). The key can
outcompete the latch for binding with the cage, exposing the cODC degron and targeting
the degronSwitch and its fused cargo to the proteasome for degradation. Furthermore, the
inducer (key) for degronLOCKR is genetically encodable, ensuring composability in
transcriptional circuit construction and distinguishing it from small molecule induced
protein degradation methods. We capitalize on this characteristic to implement modular
feedback control by directly fusing the degronSwitch to a protein of interest in a biological
network and expressing the key as a function of the network output (Fig. 3.1a).
3.3 Feedback control of yeast mating pathway
First, we used this degronLOCKR strategy to implement synthetic feedback in the yeast
MAPK mating pathway (Fig. 3.1b)72. We tested the ability of degronLOCKR to modulate
55
pathway output by inserting the degronSwitch downstream of the endogenous copy of
different pathway regulators and expressing the key using an inducible system43 (Fig. 3.1c,
top). Regulators fused to degronSwitch in either the cytoplasm or nucleus were targeted
for degradation using either a key without or with a nuclear localization sequence (NLS)
(Fig. 3.5). We stimulated the mating pathway with a saturating dose of α-factor in the
presence and absence of key and monitored pathway activity using the
pAGA1-YFP-cODC73 transcriptional reporter. Degradation of different pathway regulators
mediated by degronLOCKR had variable effects on the output of the mating pathway (Fig
3.1c, bottom), making degradation of some regulators more suitable for implementing
feedback than others. Interestingly, while degrading cytosolic Fus3 dampened the output of
the pathway, degrading nuclear Fus3 boosted the output, in accordance with previous
literature that implicates nuclear Fus3 as a repressor of mating pathway activity74.
We next implemented both synthetic negative and positive feedback control of the mating
pathway by expressing key-CFP-NLS from a mating pathway responsive promoter (pFIG1)
in a strain where either endogenous Ste12 (negative feedback) or Fus3 (positive feedback)
is fused to the degronSwitch (Fig. 3.2a). In both cases, we compared the feedback strains
to a strain without feedback, where Ste12/Fus3 is still fused to degronSwitch but the key is
expressed from a constitutive promoter. To test how feedback alters pathway behavior, we
measured pAGA1-YFP-cODC dynamics after stimulation with α-factor using automated
flow cytometry56 (Fig. 3.2b). During the time required to produce the key and activate
degronLOCKR, the output of the synthetic feedback and no feedback strains followed each
other closely. After approximately two hours, the synthetic feedback activated and drove
degradation of the degronSwitch-fused regulator as a function of pathway activity, causing
a decrease in output for negative feedback, and an increase in output for positive feedback.
The degronLOCKR synthetic negative feedback circuit displayed larger transient
overshoots for larger doses of α-factor, but eventually converged to a lower steady-state
output, whereas the output of the degronLOCKR synthetic positive feedback circuit
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continued to increase with large doses. This effect is likely not due to saturation of
signaling because different doses generated different transient responses (Fig 3.6).
For a more global comparison, we measured the steady-state output dose response of
feedback and no feedback strains as a function of α-factor. Compared to a strain with no
key expression, the negative feedback strain displayed attenuation of maximum output
magnitude and decreased slope in the linear region of the dose response, in contrast to the
positive feedback strain that displayed amplification of output and increased slope (Fig.
3.2c). To confirm this behavior is indeed generated by feedback, we also measured dose
responses of strains with different levels of constitutive key expression55. The dynamic and
steady-state measurements clearly demonstrate the effect of synthetic feedback and the
utility of degronLOCKR as a tool for rewiring a complex endogenous signaling pathway.
3.4 Feedback control of a synthetic transcriptional
cascade in yeast
We next mapped the quantitative capabilities and operational range of the degronLOCKR
feedback module using a simple synthetic transcriptional cascade consisting of two
inducible synthetic transcription factors, GEM and Z3PM43 (Fig. 3.3a). GEM is induced
by estradiol (E2) and activates pGAL1 to produce Z3PM, which is itself induced by
progesterone (Pg) and activates transcription of the output pZ3-YFP-cODC. To implement
feedback, we used the same modular strategy as in the mating pathway: fusing GEM to
the degronSwitch and using pZ3 to express key-CFP-NLS. Addition of Pg or induction of a
photosensitive degron (psd)75 fused to Z3PM perturbs the circuit, increasing or decreasing
the output, respectively. A simple computational model of the circuit (Supplementary
Information) predicts that feedback attenuates the effect of a Pg disturbance by decreasing
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the production rate of Z3PM, thereby compensating for an increase in Z3PM activity via a
decrease in its concentration (Fig. 3.3b; 3.7).
To experimentally verify these predictions, we perturbed cells that were grown to
steady-state with a high, medium, or low step-input of Pg and measured the dynamics of
pZ3-YFP-cODC using an automated flow cytometry and optogenetically-enabled
continuous culture platform56. Without feedback, the step-input of Pg caused an increase
in Z3PM activity and YFP expression until the output reached a new steady-state
commensurate with the disturbance. By contrast, the synthetic feedback circuit increased
key expression as Z3PM activity increased, resulting in GEM degradation and thus a
decrease in Z3PM production. This buffering effect is visible starting two hours
post-disturbance when the synthetic feedback circuit output begins to decrease while the
no feedback circuit output continues to climb. Because of the well-defined inputs and
disturbances, adaptation after perturbation can be quantitatively assessed (see Methods)76.
The feedback circuit achieved much greater adaptation than the circuit without feedback
for the Pg positive disturbance, showcasing one of the major benefits of feedback control in
attenuating disturbances (Fig. 3.3e).
We next tested the effect of a negative disturbance via blue light induction of the psd to
degrade Z3PM (Fig. 3.3d). After an immediate decrease in YFP expression in both the
synthetic feedback and no feedback circuits, the no feedback circuit settled to a new lower
steady-state. The feedback circuit, however, underwent a slight overshoot after which it
recovered to a steady-state closer to the pre-disturbance value than the no feedback circuit.
Model simulation shows that the negative disturbance pushes the circuit output to a lower
expression level where the relative difference between a circuit with and without feedback
will be smaller. Thus even if feedback is still actively buffering against the negative
disturbance, the effect will be harder to observe (see Supplementary Information, Fig. 3.7),
perhaps explaining the difference in the performance of the circuit between positive and
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negative perturbations (Fig. 3.3f)
We next induced the feedback and no feedback circuits with the full range of E2 and Pg
concentrations and measured both pZ3-YFP-cODC output and pGAL1-RFP (a proxy for
the activity of GEM) at steady-state (Fig. 3.8 and 3.9). At a fixed concentration of E2, the
output of the no feedback circuit increases with Pg until saturation (Fig. 3.3e) while the
RFP fluorescence is insensitive to Pg. By contrast, RFP fluorescence decreases as a
function of Pg in the synthetic feedback circuit, a result of degronLOCKR induced
degradation of GEM. This effect eventually saturates above 6.25nM Pg, as shown by the
constant RFP expression beyond this concentration. In turn, the YFP output shows
reduced sensitivity to Pg in the region of active feedback and a dramatic increase when
feedback is saturated. This behavior is a unique characteristic of the feedback circuit and is
not achievable by expressing different amounts of key constitutively (Fig 3.10). Similarly,
in the computational model, the feedback saturates when the complex formation between
the key and degronSwitch saturates (Supplementary Information; Fig 3.7).
3.5 Tuning the properties of the feedback controller
To enhance the utility of degronLOCKR feedback control, we next tackled its tunability.
The computational model predicts that tuning by either changing the strength of the
feedback promoter or the binding affinity of the key and switch yield similar tuning of
feedback properties in most parameter regimes (Fig. 3.4a; Extended Data Fig. 3.10). To
test feedback tuning via promoter strength, we used medium or weak variants of the pZ3
promoter, with four and three Z3 binding sites (BS) respectively, to drive key production in
the feedback circuit. Measurement of the Pg dose response at a fixed concentration of E2
demonstrated that weakening the promoter indeed changed the dependence of the
steady-state output on Pg (Fig. 3.4b). As the number of binding sites was reduced, the
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output dose response for the feedback circuit converged to that without feedback (Fig.
3.11). Similarly, decreasing the affinity of the key for the switch by truncating the
full-length key by four (medium) or 12 (short) residues while using the full strength pZ3
promoter (6x Z3 BS) led to a change in the dependence of the steady-state output on Pg
(Fig. 3.4c; Fig. 3.11). Reducing the strength of the feedback through either strategy also
led to larger transients and reduced adaptation (Fig. 3.12). Tuning feedback strength
through key length is an attractive alternative to promoter tuning and a unique strength of
de novo proteins.
Finally, we combinatorially tuned the synthetic negative feedback loop in the mating
pathway using both the strength of the feedback promoter and the length of the key (Fig.
3.4d). Replacing pFIG1 with the stronger promoter pAGA1 to express the key generated a
pulse of expression following induction with α-factor, while using pFIG1 as the feedback
promoter produced sustained expression (Fig. 3.4e, top; Fig. 3.14). The size of the pulse,
as well as the steady-state output following it, were both increased by reducing the key
length. Reducing the key length while using the weaker promoter pFIG1 yielded a larger
transient and higher steady-state output. Measurement of steady-state output as a
function of α-factor for different promoters and key lengths (Fig. 3.4e, bottom; Fig. 3.14)
clearly demonstrates that reducing promoter strength or key length increases the
steady-state output of the pathway and the slope of the dose response, indicating reduced
feedback strength. The tunability of degronLOCKR feedback makes it possible to achieve a
wide range of user-specified transient and steady-state characteristics.
3.6 Discussion
We have presented a plug-and-play strategy for feedback control of any biological network
with a transcriptional output. Previous methods for feedback control have relied on
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naturally occurring regulators to target specific endogenous pathways8, limiting their
modularity. In addition, the use of endogenous regulators for feedback can lead to
cross-talk with other cellular pathways, necessitating further engineering77. By contrast,
we can directly fuse the degronSwitch to a protein of interest to generate on-target
feedback on nearly any pathway of interest. The modularity of degronLOCKR extends to
mammalian cells, opening the door to a wide range of applications in therapeutics and
biotechnology. For example, degronLOCKR feedback control could improve CAR T cell
therapies by regulating the activity of synthetic receptors and internal signaling dynamics3,
or limit the production of toxic intermediates in metabolic pathways7. The degronLOCKR
based feedback circuits developed here signal the beginning of a new era of synthetic
biology based on designer proteins. A toolkit of de novo proteins could catalyze future
applications of engineered cells in the same way modular electronic parts have enabled the
explosion of the semiconductor industry78.
3.7 Methods
Construction of DNA circuits
Hierarchical golden gate assembly was used to assemble plasmids for yeast strain
construction using the method in Lee et al.55. Individual parts had their BsaI, BsmBI, and
NotI cut sites removed to facilitate downstream assembly and linearization. Parts were
either generated via PCR or purchased as gBlocks from IDT. These parts were then
assembled into transcriptional units (promoter-gene-terminator) on cassette plasmids.
These cassettes were then assembled together to form multi-gene plasmids for insertion
into the yeast genome.
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Yeast strains and growth media
The base S. cerevisiae strain used in all experiments was BY4741 (MATa his3∆1 leu2∆0
met15∆0 ura3∆0). All yeast cultures were grown in YPD media (10 g/L Bacto Yeast
Extract, 20 g/L Bacto peptone, 20 g/L dextrose). Selection of auxotrophic markers
(URA3, LEU2, and/or HIS3) was performed on synthetic complete medium (6.7 g/L
Bacto-yeast nitrogen base without amino acids, 2 g/L complete supplement amino acid
mix, 20 g/L dextrose).
Knockouts of FAR1 and BAR1
A modified version of BY4741 (yAHN797) was created for the mating pathway experiments
with FAR1 and BAR1 knocked out using the CRISPR/Cas9 method outlined in Lee et al.
FAR1 was first targeted by two sgRNAs designed using the Benchling biology design tool
to target the ORF of each gene. These sgRNAs were expressed on CEN6/ARS4 plasmids
containing a Cas9 with two nuclear localization sequences and a URA3 auxotrophic marker.
Repair DNA with homology to the 50bp upstream and downstream of the ORF was
generated by annealing oligos. A standard lithium acetate procedure was used to transform
yeast with the plasmid containing sgRNA/Cas9 and repair DNA. The efficacy of sgRNA
was assessed by comparing the number of colonies of transformants given repair DNA with
respect to transformants that were not provided repair DNA. Colonies were screened by
colony PCR to verify the knockout, and successful clones were grown in an overnight
culture of YPD. 5 ul of overnight culture was then plated on synthetic complete medium
containing 5-fluoroorotic acid (5-FOA) to counterselect the URA3 auxotrophic marker on
the CEN6/ARS4 plasmid. The knockout process was then repeated to knock out BAR1.
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Integration of degronSwitch into yeast genome
Oligonucleotides were designed with 80bp of homology to target the C-terminus of STE20,
STE11, MSG5, PTP3, STE12, DIG1, DIG2, and FUS3. Linear DNA was generated using
PCR with the targeting oligonucleotides and a template of 5xGS-degronSwitch upstream of
a URA3 auxotrophic marker. Individual lithium acetate yeast transformations were then
performed to insert each of the linear DNA fragments into the parental strain yAHN797.
Selection was performed on synthetic complete plates lacking uracil and insertions were
confirmed using colony PCR.
Yeast cell culture and induction
Yeast strains were streaked out from a glycerol stock on SDC plates with the appropriate
auxotrophic marker, or YPD plates if no auxotrophic marker was present. Individual
colonies from these plates were used to inoculate a culture in YPD to grow to saturation
over 12-24 hours.
Testing effect of degronLOCKR on yeast mating pathway
Saturated culture was diluted 1:500 in fresh YPD and 400ul was aliquoted into individual
wells of a 2 mL 96 well storage block (Corning) for a three hour outgrowth at 30C and
900RPM in a Multitron shaker (Infors HT). α-factor mating pheromone (Zymo Research)
and progesterone (Fisher Scientific) were prepared at a 10x concentration by making the
appropriate dilutions into YPD. After the 3 hour outgrowth, 50ul of α-factor and 50ul of
progesterone solution was added to the 96 well block and the block was returned to the
shaker for four hours before measurement with flow cytometry.
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α-factor induction
Saturated culture was diluted 1:500 in fresh YPD and 450ul was aliquoted into individual
wells of a 2 mL 96 well storage block (Corning) for a three hour outgrowth at 30C and
900RPM in a Multitron shaker (Infors HT). α-factor mating pheromone was prepared at a
10x concentration by making the appropriate dilutions into YPD from a 50uM stock
solution (Zymo Research). After the 3 hour outgrowth, 50ul of α-factor solution was added
to the 96 well block and the block was returned to the shaker for four hours before
measurement with flow cytometry.
Estradiol and Progesterone induction
Saturated culture was diluted 1:500 in fresh YPD and 400ul were aliquoted into individual
wells of a 2 mL 96 well storage block (Corning) for a three hour outgrowth at 30C and
900RPM in a Multitron shaker (Infors HT). Estradiol (Sigma-Aldrich) and progesterone
(Fisher Scientific) were prepared at a 10x concentration by making the appropriate
dilutions into YPD from a 3.6mM (estradiol) and 3.2mM (progesterone) stock solution.
After the three hour outgrowth, 50ul of estradiol and progesterone inducer were added to
the 96 well block in the appropriate combinations and the block was returned to the shaker
for ten hours before measurement with flow cytometry.
Description of automated flow cytometry and continuous culture
system
Hardware We adapted an existing automated experimental platform56 to perform
variable concentration small molecule induction and long-term culturing. Yeast cultures
were grown in 50 mL optically clear conical tubes (Falcon) that were held in eight custom
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temperature-controlled, magnetically stirred chambers. Each bioreactor is equipped with
an individual blue LED that is connected to a USB controllable LED driver (Mightex).
Liquid handling was accomplished using a 14 position stream selector (VICI Cheminert)
and two syringe pumps (Cavro XCalibur Pump, TECAN) of a BD High-Throughput
Sampler. Commands to the HTS were controlled using LABVIEW 2013. This setup
allowed for periodic sampling and dilution of individual cultures. Each sampling period
consisted of three main steps: 1) send sample to flow cytometer for measurement, 2)
extract culture and send to waste, and 3) replenish culture with fresh media at desired
hormone concentration. Each sampling period can be designated to either induce cultures
to a new higher hormone concentration or to maintain desired hormone concentration.
Sampling frequency and dilution volume were selected to avoid saturation of culture based
on the duration of the experiment. For experiments longer than six hours, a sampling
frequency of 25 minutes and a dilution volume of 4 mL were used. For experiments shorter
than six hours, continuous culturing was not performed. Instead, one induction at t=0 was
performed by extracting 2mL of culture and replenishing with fresh media with hormone.
A sampling frequency of 10 minutes was used.
Yeast culture Saturated culture was diluted 1:200, or 1:100 for mating pathway cultures,
into fresh YPD. Cultures were grown for 2 hours in glass tubes at 30C and 250RPM in a
Innova 44 shaker (New Brunswick). Cultures were then diluted to 0.01 OD600 in fresh
YPD and aliquoted into individual 50 mL optically clear conical tubes (Falcon) at a total
volume of 30mL YPD. Another one hour outgrowth was performed in bioreactors with
magnetically-controlled stir bars at 30C. All YPD media was supplemented with
5,000U/mL Penicillin Streptomycin (Thermo-Fisher).
α-factor induction A 1X concentration was determined by the highest desired α-factor
concentration at which to test strains (25nM). YPD media was prepared at two
concentrations: (1) 15X α-factor concentration and (2) no α-factor. After a one hour
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outgrowth in bioreactors (t=0 hr), induction was performed by extracting 2mL from all
cultures and replenishing with various ratios of (1) and (2) to achieve desired
concentrations. Sampling proceeded without continuous culturing.
Estradiol and progesterone induction for testing positive disturbance rejection
A 1X concentration was determined by the highest desired hormone concentration at which
to test strains (7.5nM E2/6.5nM Pg). A solution of hormone and YPD media was created
at a 7.5X concentration to bring pre-induced cultures to a desired concentration in one
sampling period. A second solution of hormone and YPD media was created at a 6.7X
concentration to induce cultures from their pre- to post- disturbance hormone
concentrations. YPD media was prepared at four different concentrations of hormone: (1)
7.5X E2/7.5X Pg, (2) 1X E2/6.7X Pg, (3) 1X E2/1X Pg, and (4) 1X E2/no Pg. After a
one hour outgrowth in bioreactors (t=-10 hr), the first induction was performed to achieve
a pre-disturbance hormone concentration by extracting 4mL from all cultures and
replenishing with (1). After induction, sampling proceeded as described above (see
Hardware). All sampling periods following the induction time point included sending a
sample to the cytometer for measurement, extracting 4mL from all cultures, and
replenishing cultures with a mixture of (3) and (4) to maintain the desired hormone
concentration. During the second induction time point (t=0 hr), cultures were induced to
achieve a post-disturbance hormone concentration with different ratios of (2) and (4). This
induction was followed by the same procedure as the first induction, except that hormone
concentrations were maintained by adjusted ratios of (3) and (4).
Estradiol, progesterone, and light induction for testing negative disturbance
rejection A 1X concentration was determined by the highest desired hormone
concentration at which to test strains (30nM E2/1.57nM Pg). A solution of hormone and
YPD media was created at a 7.5X concentration to bring pre-induced cultures to a desired
concentration in one sampling period. YPD media was prepared at three different
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concentrations of hormone: (1) 7.5X E2/7.5X Pg, (2) 1X E2/1X Pg, and (3) no hormone.
After a one hour outgrowth in bioreactors (t=-10 hr), the first induction was performed to
achieve a pre-disturbance hormone concentration by extracting 4mL from all cultures and
replenishing with (1). After induction, sampling proceeded as described above (see
Hardware). All sampling periods following the induction time point included sending a
sample to the cytometer for measurement, extracting 4mL from all cultures, and
replenishing cultures with a mixture of (2) and (3) to maintain the desired hormone
concentration. Starting at the light induction time point (t=0 hr), cultures were exposed to
a saturating light dose (45 seconds on/15 seconds off with an intensity amplitude of 25mA)
for the remainder of the experiment. Hormone concentrations were maintained throughout
the entire experiment.
Estradiol and progesterone induction for testing synthetic tuning A 1X
concentration was determined by the highest desired hormone concentration at which to
test strains (7.5nM E2/3.13nM Pg). A solution of hormone and YPD media was created at
a 7.5X concentration to bring pre-induced cultures to a desired concentration in one
sampling period. YPD media was prepared at three different concentrations of hormone:
(1) 7.5X E2/7.5X Pg, (2) 1X E2/1X Pg, and (3) no hormone. After one hour outgrowth in
bioreactors (t=0 hr), cultures were induced. 4mL were first extracted from all cultures,
then replenished with different ratios of (1) and (3) in order to achieve desired hormone
concentrations. After induction, sampling proceeded as described above (see Hardware).
All sampling periods following the induction included sending samples to the cytometer for
measurement, extracting 4mL from all cultures, and replenishing cultures at their
respective hormone concentrations by adjusted ratios of (2) and (3).
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Flow cytometry
Analysis of fluorescent protein reporters expression was performed with a BD LSRII flow
cytometer (BD Biosciences) equipped with a high-throughput sampler. For steady-state
measurements, cultures were diluted in TE before running through the instrument to
obtain an acceptable density of cells. YFP (Venus) fluorescence was measured using the
FITC channel and RFP (mKate2) was measured using the PE-Texas Red channel. For
steady-state measurements, 5,000-10,000 events were collected per sample. For dynamic
measurements, the first 750 events of sample were discarded, and 2,000-10,000 events were
collected per sample. Fluorescence values were calculated using the height (H)
measurement for the appropriate channel and normalized to cell size by dividing by side
scatter (SSC-H). All analysis of flow cytometry data was performed in Python 2.7 using
the package FlowCytometryTools and custom scripts.
Precision calculations Precision for a progesterone disturbance was calculated as follows:
(
‖Y FPpost−Y FPpre‖
Y FPpre
‖Pgpost−Pgpre‖
Pgpre
)−1, where YFPpost is the steady-state YFP fluorescence value
post-disturbance, YFPpre is the steady-state YFP fluorescence value pre-disturbance,
Pgpost is the post-disturbance progesterone concentration, and Pgpre is the
pre-disturbance progesterone concentration. For light disturbance, precision was calculated
as follows: ‖Y FPpost−Y FPpre‖
Y FPpre
−1
Hill function fitting The mean of triplicate data from each α-factor dose response was
used to fit a hill function of the following form: F (α) = Fmin + (Fmax − Fmin) ∗ αnKnm+αn ,
where F is the mean fluorescence, Fmin is the basal fluorescence, Fmax is the maximum
fluorescence, Km is the α-factor concentration at which half-maximal fluorescence is
achieved, and n is the hill coefficient. Fitting was performed in Python 2.7 using the Scipy
package and the curvefit function.
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3.10 Figures
Figure 3.1: degronLOCKR is a modular tool for controlling biological pathways.
a. degronLOCKR strategy for implementing synthetic feedback control. b. Simplified
schematic of the yeast mating pathway not showing endogenous feedback. Pathway is
activated by addition of α-factor and signaling activity is measured using a
pAGA1-YFP-cODC reporter (cODC degron destabilizes the fluorescent reporter for
measurement of dynamic pathway activity). c. degronLOCKR induced degradation of
mating pathway regulators. The endogenous copy of indicated protein was fused to
degronSwitch and key was expressed using a progesterone inducible system. Cells were
induced with a saturating dose of α-factor (100nM) and pathway activity with (50nM Pg)
and without (0nM Pg) key was compared. Data represent mean ± s.d. of three biological
replicates.
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Figure 3.2: degronLOCKR implementation of synthetic feedback on the mating pathway.
a. Schematic of synthetic negative and positive feedback where the endogenous copy of
Ste12 (left) or Fus3 (right) is fused to the degronSwitch and either a pathway reporter
pFIG1 (synthetic feedback) or a constitutive promoter (no feedback) is used to express
key-CFP-NLS. All output measurements are for pAGA1-YFP-cODC. b Output dynamics
for synthetic negative (left) and positive (right) feedback. Synthetic feedback and no
feedback (pREV1) strains were induced at time 0 hrs and flow cytometry measurements
(points) were performed every 10 minutes. Lines represent a moving average taken over
three data points. c Comparison of α-factor dose response of synthetic negative (left) and
positive (right) feedback. Feedback implemented using pFIG1 was compared to no
feedback strains with different levels of constitutive key expression. Solid lines are a hill
function fit to the data. Doses of α-factor from the experiment in (b) are indicated by
arrows. Data in all panels represent mean ± s.d. of three biological replicates.
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Figure 3.3: Quantifying properties of degronLOCKR feedback via control of a synthetic
circuit
a. Schematic of synthetic feedback circuit. GEM-degronSwitch is expressed constitutively
and is activated by estradiol (E2) to drive expression of pGAL1-Z3PM-psd and
pGAL1-RFP. Z3PM is activated by progesterone (Pg) to drive expression from pZ3. Blue
light induces degradation of Z3PM-psd. pZ3-YFP-cODC is the measured output of the
circuit, and pZ3-key-CFP-NLS drives feedback in the circuit by activating degradation of
GEM-degronSwitch. In the circuit with no feedback a constitutive promoter is used to
express key-CFP-NLS. b Model simulation of the feedback and no feedback circuits. The
simulated dynamics following a Pg disturbance (left) and steady-state (right) of output
indicate that feedback buffers against increasing Pg concentration by degrading GEM and
reducing Z3PM concentration. c Dynamic measurements of output for the synthetic
feedback and no feedback strains (pRNR2-key-CFP-NLS) following a positive disturbance.
Cells were grown to steady-state expression in 0.78nM Pg and 7.5nM E2. At time 0 hrs
cells were either kept at the same Pg concentration or induced to a new final concentration
of 1.56 nM (low), 3.13 nM (med), or 6.25 nM (high) Pg. Dynamics were measured for
another ten hours. d Dynamic measurements of output for the synthetic feedback and no
feedback strains (pRPL18B-key-CFP-NLS) following a negative disturbance. Cells were
grown to steady-state expression in 1.57nM Pg and 30nM E2 then subjected to blue-light
at time 0 hrs to activate the psd. Dynamics were measured for another ten hours. Solid
lines in (c) and (d) represents a moving average taken over three data points. e Precision
of the synthetic feedback versus no feedback circuits to each of the disturbances. f
Comparison of steady-state circuit behavior with and without feedback
(pRNR2-key-CFP-NLS) as a function of Pg at a fixed concentration of 7.5nM E2. RFP
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fluorescence is a proxy for Z3PM concentration and YFP fluorescence is the output of the
circuit. Pg doses used for positive disturbance in c) are indicated. Data in all panels
represent mean ± s.d. of three biological replicates.
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Figure 3.4: degronLOCKR synthetic feedback strategy is tunable
a Exploring different tuning methods for feedback via model simulation of circuit output
and Z3PM as a function of Pg disturbance for decreasing promoter strength of key length.
b and c) Experimental validation of tuning. b (Top) Tuning feedback by varying the
number of Z3 binding sites on pZ3 with the key at a fixed length. (Bottom) RFP and YFP
fluorescence as a function of Pg for strong (pZ3-6x), medium (pZ3-4x), and weak (pZ3-3x)
feedback strains versus no feedback (pREV1-key-CFP-NLS) strain. c (Top) Tuning
feedback by varying the length of the key with the strength of the feedback promoter fixed
at pZ3-6x. (Bottom) RFP and YFP fluorescence as a function of Pg for long (55 aa),
medium (51 aa), and short (43 aa) key feedback strains versus no feedback
(pREV1-key-CFP-NLS) strain. d Changing promoter strength and key length to tune
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feedback on the synthetic negative feedback loop in the mating pathway. pAGA1 is a
stronger reporter of the mating pathway than pFIG1. e (Top) Dynamic measurements of
pAGA1-YFP-cODC for various feedback and no feedback strains following α-factor
stimulation. Solid line represents a moving average taken over three data points. (Bottom)
α-factor dose response of feedback strains versus a no feedback (pREV1-key-CFP-NLS)
strain. Solid lines are a hill function fit to the data. The dose of α-factor used in the
dynamic experiment (top) is indicated by the arrow. Data in all panels represent mean ±
s.d. of three biological replicates.
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3.11 Extended Data Figures
Figure 3.5: Panel of mating pathway regulators tested with degronLOCKR.
degronSwitch was fused to the C-terminus of the endogenous copy of each regulator. Key
with or without SV40 NLS was expressed using a Pg inducible system. STE20, STE11, and
PTP3 were degraded using cytoplasmic key (Key-CFP), and STE12, DIG1 and DIG2 were
degraded using nuclear key (Key-CFP-NLS). MSG5 and FUS3 were degraded using either
cytoplasmic (cyto) or nuclear (nuc) key. Cells were induced with 1nM (low) or 100nM
(high) α-factor and 50nM or 0nM Pg and grown for four hours before YFP fluorescence was
measured using a flow cytometer. Data represent mean ± s.d. of three biological replicates.
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Figure 3.6: Dynamic measurements of mating pathway with synthetic feedback.
degronSwitch is fused to the C-terminus of the endogenous copy of STE12 (left) and FUS3
(right). Measurements of pAGA1-YFP-cODC dynamics for synthetic negative (left) and
positive (right) feedback. Synthetic feedback and no feedback (pREV1) strains were
induced with 25, 12.5, 6.25, or 3.13nM α-factor at time t=0hr and flow cytometry
measurements (points) were performed every 10 minutes. Points represent the mean ±s.d.
of three biological replicates. Lines represent a moving average taken over three data
points.
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Figure 3.7: Model analysis of synthetic transcriptional circuit with degronLOCKR feedback
to probe steady state solutions in response to positive or negative disturbances.
Steady values as a) progesterone (Pg) or b) ZPM degradation rate (γZ) change according
to Hill-like model (see Supplementary Information - Model Description). Continuous lines
correspond to the feedback system (FB), while the dashed line shows an example where the
feedback has been removed. The gray box delimits the area where the feedback is
considered active. This is defined by the relative change in total GEM
(∆(G+C)/(G+C)) over the relative change of the disturbance (either ∆P/P for panel a)
or ∆γZ/γZ for panel b) ) being higher than 0.15. IN the absence of feedback, ∆(G+ C) is
equal to zero for any disturbance, unless the disturbance directly affects the synthesis or
degradation rate of the key or GEM. The parameters used are shown in Supplementary
Information - Model Description.
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Figure 3.8: Behavior of synthetic transcriptional circuit with degronLOCKR feedback as a
function of Pg for a fixed dose of E2.
a. Comparison of steady-state circuit behavior (ten hours after stimulation) with and
without feedback (pRNR2-key-CFP-NLS) as a function of Pg at all concentrations of E2.
YFP fluorescence is the output of the circuit and RFP fluorescence is a proxy for Z3PM
concentration. Points represent mean ± s.d. of three biological replicates. b. Example of
gating strategy used to generate flow cytometry data. Cells used are in Q2.
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Figure 3.9: Behavior of synthetic transcriptional circuit with degronLOCKR feedback as a
function of E2 for a fixed dose of Pg.
Comparison of steady-state circuit behavior (ten hours after stimulation) with and without
feedback (pRNR2-key-CFP-NLS) as a function of E2 at all concentrations of Pg. YFP
fluorescence is the output of the circuit and RFP fluorescence is a proxy for Z3PM
concentration Points represent mean ± s.d. of three biological replicates.
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Figure 3.10: Behavior of synthetic transcriptional circuit with degronLOCKR feedback can-
not be matched by expressing different amounts of key constitutively.
Comparison of steady-state circuit behavior (ten hours after stimulation) with feedback
and various levels of key expression without feedback (pREV1, pRNR2, pRET2,
pRPL18B) as a function of Pg at a fixed concentration of 7.5nM E2. YFP fluorescence is
the output of the circuit and RFP fluorescence is a proxy for Z3PM concentration. Points
represent mean ± s.d. of three biological replicates.
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Figure 3.11: Model analysis of synthetic transcriptional circuit with degronLOCKR feedback
to probe the effect of changing η+ or µK
a-b) Steady values as progesterone (Pg) changes according to Hill-like model (see
Supplementary Information - Model Description). Continuous lines correspond to the
feedback system (FB), while the dashed line shows an example where the feedback has
been removed. The effect of decreasing (x0.01) or increasing (x100) either a) η+ or b) µK
are shown in orange and purple, respectively. The shadow boxes delimit the area where the
feedback is considered active (∆(G+ C)/(G+ C)/∆P/P > 0.15) for each case (gray -
original parameter set; orange - decreasing a) η+ or b) µK ; purple - increasing a) η+ or b)
µK). c-d) The bottom panels show how the range of feedback activity for Pg disturbances
changes as a) η+ or b) µK vary (see color bar on the left). The vertical lines correspond to
the cases shown in panels a and b, respectively. The used parameters are shown in
Supplementary Information - Model description.
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Figure 3.12: Changing promoter strength or key length modulates feedback properties for
synthetic transcriptional circuit with degronLOCKR feedback.
Comparison of steady-state circuit behavior (ten hours after stimulation) for various levels
of feedback (left, tuning via changing feedback promoter strength; right, tuning via
changing key length) as a function of Pg at a fixed concentration of 7.5nM E2. Left, tuning
via changing feedback promoter strength (x refers to number of Z3 operator sites); right,
tuning via changing key length (m refers to number of residues removed from C- terminus
of key). YFP fluorescence is the output of the circuit, RFP fluorescence is a proxy for
Z3PM concentration, and BFP fluorescence is the amount of key produced. Points
represent mean ± s.d. of three biological replicates.
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Figure 3.13: Tuning feedback strength changes dynamic behavior of output of synthetic
transcriptional circuit with degronLOCKR feedback.
Dynamic measurements of pZ3-Venus-cODC using automated flow cytometry for the
synthetic feedback strain with various strengths and no feedback strain
(pREV1-key-CFP-NLS) following induction with 3.13nM Pg and 7.5nM E2 at time=0hrs.
Solid line represents a moving average taken over three data points and points represent
the mean ± s.d. of three biological replicates.
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Figure 3.14: Combinatorial tuning of synthetic negative feedback in mating pathway.
(Top) Dynamic measurements of pAGA1-YFP-cODC for various feedback and no feedback
(pREV1, pRNR2, pRET2, pRPL18B) strains with Ste12 fused to degronSwitch following
stimulation with 25nM α-factor. Solid line represents a moving average taken over three
flow cytometry data points and points represent the mean ± s.d. of three biological
replicates. (Bottom) α-factor dose response of feedback strains versus no feedback
(pREV1, pRNR2, pRET2, pRPL18B) strains. YFP fluorescence was measured using flow
cytometry four hours after α-factor induction. Points represent mean ± s.d. of three
biological replicates. Solid lines are a hill function fit to the data.
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3.12 Supplementary Information
3.12.1 Model description
We describe below the computational model used to generate all plots in the manuscript.
Species
• G : degSwitch-transcription factor (e.g. degSwitch-GEM)
• Z : Transcription factor (e.g. ZPM)
• K : Key
• C : Key-degSwitch-transcription factor complex
• Y∗ : ”Immature” output (e.g. immature YFP)
• Y : Output (e.g. mature YFP)
Parameters
• µG ([nM/min]) : Constitutive synthesis rate of G
• γG ([1/min]) : Degradation/loss rate of free G (i.e. leaky degradation)
• η+ ([1/(nM min)]) : Binding rate of G and K
• η0 ([1/min]) : Unbinding rate of G and K
• η− ([1/min]): Active degradation rate of G in the complex form (i.e. C → K)
• fZ(G+ C,E) ([nM/min]) : Synthesis rate of Z regulated by G and E (e.g.
µZ · (G+ C) · E)
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• E ([nM]) : Co-factor of G to regulate Z synthesis (e.g. estradiol)
• γZ ([1/min]) : Degradation/loss rate of Z
• fK(X,P ) ([nM/min]) : Synthesis rate of K regulated by Z and P (e.g. µK ·X · P )
• P ([nM]): Co-factor of Z to regulate K synthesis (e.g. progesterone)
• γK ([1/min]) : Degradation/loss rate of K and C
• fY (X,P ) ([nM/min]) : Synthesis rate of Y regulated by Z and P (e.g. µY ·X · P )
• γY ([1/min]) : Degradation/loss rate of Y
• κ+ ([1/min]) : Maturation rate of Y∗
ODE system
d
dt
G = µG − γGG− η+GK + η0C (3.1)
d
dt
Z = fZ(G+ C,E)− γZZ (3.2)
d
dt
K = fK(Z, P )− γKK − η+GK + (η0 + η−)C (3.3)
d
dt
C = −γKC + η+GK − (η0 + η−)C (3.4)
d
dt
Y∗ = fY (Z, P )− γY Y∗ − κ+Y∗ (3.5)
d
dt
Y = κ+Y∗ − γY Y (3.6)
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3.12.2 Qualitative properties
Notice that in this system (Eqs. 3.1-3.5), total K concentration (i.e. KT = K + C) and
output YT are given by:
d
dt
KT =
d
dt
(K + C) = fK(Z, P )− γK(K + C) (3.7)
d
dt
YT =
d
dt
(Y∗ + Y ) = fY (Z, P )− γY (Y∗ + Y ) (3.8)
assuming fK(Z, P ) and fY (Z, P ) have similar qualitative form (e.g. fK(Z, P ) ∝ fY (Z, P )),
then KT and YT have analogous functional form.
At steady state :
d
dt
G = 0 ⇔ Gss = µG + η0Css
γG + η+Kss
(3.9)
d
dt
C = 0 ⇔ Css = η+GssKss
γK + η0 + η−
⇒ C = µGKss
γG(
γK+η0+η−
η+
) +Kss(γK + η−)
(3.10)
Then, when Kss  γG(γC+η0+η−)η+(γC+η−) , the Css ≈
µG
γK+η−
. This occurs regardless of the specific
form of d
dt
K, and in particular the presence or absence of feedback. This is actually an
important limit in the control system, as the feedback action occurs through and only
through C formation, and this is a required step for active degradation –and then the
feedback– to occur. For example, consider that fK(z, P ) is an increasing function of Z and
P and consider a positive disturbance implemented through an increase in P : initially, as
P increases, K synthesis increase, potentially increasing C and then the effective active
degradation of G. Once G decreases, the synthesis of Z will decrease accordingly,
decreasing then K synthesis, i.e. “compensating” for the increment on P . Nevertheless, if
C has reached its maximum value (limK→∞C =
µG
γK+η−
), increasing K does not have an
effect on G degradation, and the feedback is effectively broken.
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3.12.3 Basal activity & saturation on synthesis functions
We incorporate the complexity of the synthesis process by using a Hill-type function as the
synthesis function for each of the regulated genes:
fZ(G+ C,E) = µZ
(
αZ + (1− αZ) (E · (G+ C))
nZ
(E · (G+ C))nZ +KnZZ
)
(3.11)
fK(Z, P ) = µK
(
αK + (1− αK) (P · Z)
nK
(P · Z)nK +KnKK
)
(3.12)
fY (Z, P ) = µY
(
αY + (1− αY ) (P · Z)
nK
(P · Z)nK +KnKK
)
(3.13)
where µ∗ represents the maximum synthesis rate, α∗µ∗ is the basal synthesis rate, n∗ is the
Hill coefficient, and K∗ is the activation threshold relative to the active regulator (i.e.
transcription factor and co-factor complex). We assume that the Hill coefficient and
activation threshold are the same for K and Y synthesis function, as they are both
regulated by Z and P ; the maximum and basal synthesis rate are expected to depend more
strongly on the gene sequence, and then we allow them to differ.
The Hill function is often used as a phenomenological description of gene regulation.
Nevertheless, regardless of the specific form of f∗ functions, a basal and a maximum
synthesis rate are expected for every gene. The functions in Eqs. 3.11-3.13 allow us to
explore the effect of these limits.
Figure 3.7a shows an example of the steady state results for different values of P using this
model (Eqs. 3.11-3.13). As expected, the feedback is active only when C is neither too
small nor too high. We define the feedback as “active” whenever the relative change in
total G (GT = G+ C) over the relative change of the P -disturbance is higher than an
arbitrary threshold (e.g.  = 0.15):
(∆GT )/GT
(∆P )/P
≥  (3.14)
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Feedback directly changes the amount of GT , thus this metric is useful because the amount
of feedback is correlated to the sensitivity of GT to the P -disturbance. The value of ∆GT
as well as the metric in Eq. 3.14 are equal to zero in an system without feedback.
Similar to perturbing the system by increasing the concentration of P , it is possible to test
the feedback action by perturbing the degradation rate of Z (see 3.3 in the main text). Fig
3.7 shows that this “negative” perturbation has a similar response compared to the
previous “positive” perturbation (Fig 3.7), just changing the direction of the effect of the
perturbation (i.e. Z increases as γZ increases, to “compensate” for the faster degradation
of X). Once again, the feedback control is active (substituting ∆(P )/P by ∆(γZ)/γZ in
Eq. 3.14) when C has not reach saturation and its concentration is high enough to
contribute significantly to the degradation of GT .
3.12.4 Tuning the feedback efficiency
Fig 3.11 shows a few examples of how steady state solution and feedback “activity” regime
varies as either η+ or µK change. In both cases, decreasing the parameter value initially
shifts the feedback “activity” regime towards higher P -disturbance values (Fig 3.11), and
eventually breaks the feedback reducing both the range and magnitude of the feedback
activity (as defined by Eq. 3.14). Nevertheless, for high values of η+, the sensitivity of GT
increases dramatically, compared to high values of µK , where the feedback actually
saturates and eventually breaks. Therefore, systems with higher η+ can potentially result
in a stronger and more efficient feedback. Nevertheless, Fig 3.11 shows an example where
the feedback activity occurs where the output Y expression is very close to its basal value,
making the benefit of this increment of η+ almost imperceptible (compare black and purple
continuous lines in Fig 3.11). In this case, decreasing the basal expression of Y would be
enough to reveal the feedback action on this system. This example highlights the
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advantage of defining this model to do a full tuning of the experimental system.
Table 3.1: Simulation parameter values in Figures & Extended Data Figures
µG γG η+ η0 η− µZ αZ nZ KZ E γZ
Fig. nM min−1 nM−1 min−1 min−1 nM nM nM min−1
min−1 min−1 min−1
3b 0.006 0.02 0.0375 1E-4 0.05 11 1E-6 2.2 36 7.5 0.01
4a 0.006 0.02 0.0375∗ 1E-4 0.05 11 1E-6 2.2 36 7.5 0.01
E2a 0.006 0.02 0.0375 1E-4 0.05 11 1E-6 2.2 36 7.5 0.01
E2b 0.006 0.02 0.0375 1E-4 0.05 11 1E-6 2.2 36 30 0.01
E7a,c 0.006 0.02 0.0375† 1E-4 0.05 11 1E-6 2.2 36 7.5 0.01
E7b,d 0.006 0.02 0.0375 1E-4 0.05 11 1E-6 2.2 36 7.5 0.01
µK αK nK KK P γK µK∗‡ µY αY γY κ+
Fig. nM nM nM min−1 nM nM min−1 min−1
min−1 min−1 min−1
3b 2 1E-5 2.6 12 [0.8, 3]† 0.01 0.0028 0.75 0.03 0.05 0.01
4a 2∗ 1E-5 2.6 12 ...† 0.01 5E-4 0.75 0.03 0.05 0.01
E2a 2 1E-5 2.6 12 ...† 0.01 0.0028 0.75 0.03 0.05 0.01
E2b 2 1E-5 2.6 12 1.57 0.01 0.28 0.75 0.03 0.05 0.01
E7a,c 2 1E-5 2.6 12 ...† 0.01 5E-4 0.75 0.03 0.05 0.01
Eb,d 2† 1E-5 2.6 12 ...† 0.01 5E-4 0.75 0.03 0.05 0.01
‡ “No feedback” system.
† Unless directly perturbed.
∗ When η+ is “tuned”: η+ = [0.01125, 0.001125] nM−1 min−1;
when µK is “tuned”: µK = [0.2, 0.02] nM min
−1.
NOTE: E# refers to Extended Data Figure #.
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Chapter 4
Conclusions
In this work, we sought to expand the possibilities for feedback control in biological
systems. Our original motivation was the construction of an integral controller via a
mechanism known as antithetic feedback69 to generate perfect adaptation, but
degronLOCKR feedback does not neatly fit this classification. The reason for the deviation
from integral control is that the Key does not degrade after binding the degronSwitch. We
tested several mechanisms for introducing co-degradation, including the use of a
SpyCatcher-SpyTag79 system to induce covalent bond formation between the Switch and
Key, as well as the introduction of orthogonal degronLOCKR to generate SwitchA-KeyC
fusions that would induce mutual degradation. Unfortunately, neither of these strategies
were able to induce co-degradation of the Key. Addition of these parts tended to break the
activation of the Switch, either leaving it in a fully-open or fully-closed state. Future work
could include redesign of the Switch to accommodate fusion of an orthogonal Switch, or
further optimization of the SpyCatcher-SpyTag system. It may also be possible to design
completely new peptide inducible, or split-degron systems. One example of another system
that could potentially generate the desired co-degradation is a pair of co-inactivating
proteases taken from CHOMP (cite). A split-intein80 system could also be repurposed into
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a split-degron system to achieve degradation only in the presence of both parts.
Although degronLOCKR feedback is not integral control, we were still able to achieve
adaptation to disturbances. Is the feedback controller still useful? In my opinion, the most
useful feedback controller is one that can most easily be used in a variety of applications.
DegronLOCKR feedback fits this description as the most modular implementation of
feedback to date. However, work must still be done to improve qualities of the feedback
controller such as rejection of negative disturbances and more robust adaptation. More
broadly, this raises the question of how to perform quantitative comparisons between
different types biological feedback mechanisms. What are metrics that can be used to
evaluate feedback, and how different systems be under different real-world stress
situations? We began to tackle this question by developing a metric to quantify when the
feedback in our circuit was active, but a thorough comparison to other feedback
architectures still needs to be performed. Further development in this direction may lead
to solving the inverse problem - the design of new feedback architectures that can achieve
certain performance characteristics for a given system.
Using this type of framework for evaluating biological feedback controllers, one can begin
to answer the more philosophical question of how to design feedback controllers for use in
biological systems. Complex theory has been developed regarding the design and synthesis
of feedback controllers for physical systems, but properties of biological substrates such as
saturation, nonlinearity, and non-negative concentrations, limit the translation of such
theory to biological systems. Translation of concepts such as integral control or the more
complex PID control81 (proportional-integral-derivative) is possible but challenging, often
requiring approximations and assumptions based on the limitations described above to fit
our conception of ideal controllers. While this work certainly has merit, we should consider
that living systems have thus far survived the test of time without evolving feedback
control systems that perfectly fit the definitions we have invented. How do cells withstand
93
environmental stresses and perturbations without PID controllers? It is perhaps wise to
look to biology and evolution for inspiration as to how to best design robust feedback
controllers given the limitations of the substrate.
The use of degronLOCKR to implement feedback is just the first example of what may be a
new paradigm in synthetic biology - designer proteins in synthetic circuits. As the number
of tools available to synthetic biology continues to expand, the possibilities available for
engineering feedback and other circuits in cells will only grow. The maturation of protein
design may greatly contribute to this expansion via the on-demand design of biorthogonal
parts that can serve a given application. By integrating protein design with cell
engineering, we may begin to truly be limited by our imaginations rather than available
tools. This may bring us closer to directly translating concepts such as integral control
from the field of electrical engineering to biological systems. The parallel pursuit of new
feedback architectures in combination novel synthetic biology tools developed using protein
design will lead to an explosion in the capability of cell engineers to program cells.
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